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ABSTRACT 
 
  
The use of adult hepatic stem cells for the treatment of diabetes, based both on the close 
embryological association of the pancreas and liver, and on a putative shared tissue stem 
cell, has been proposed by a number of studies. This study investigated the capacity of 
hepatic oval cells to differentiate into pancreatic endocrine cells in the presence of 
pancreatic mesoderm. The GaIN model of hepatic injury was used to induce oval cell 
activation in Male Sprague-Dawley rats. A viable and significant oval cell population 
could not however, be isolated and propagated in culture. In order to continue 
experimentation, a PHeSC-A2 cell line, derived from normal adult porcine liver, was 
cultured with quail pancreatic mesoderm in the GFRM-Hams F12.ITS culture system. 
Cells demonstrating positive immulocalization of the pancreatic markers, insulin and 
glucagon, were identified as PHeSC-A2-derived, by visual assessment of their nuclear 
morphology. Techniques used to confirm these results and preclude the derivation of the 
pancreatic endocrine cells from pancreatic endodermal contamination, proved ineffectual. 
The tentative results obtained in this study have lead to the following postulations: firstly, 
the PHeSC-A2 cell line may possess a higher level of potentiality than previously 
demonstrated; secondly, this potential may be due to the shared embryological origins of 
the pancreas and liver, and thirdly, permissive signaling from pancreatic mesoderm may 
have the capacity to induce the differentiation of hepatic oval cells into pancreatic 
endocrine cells. Further research is required to confirm the results obtained in this study 
and to substantiate the aforementioned propositions.  
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Figure 1. A photomicrograph illustrating a quail embryo at stage 25 (Hamburger and 
Hamilton, 1951). Stereomicroscopy. 60X. 
 
Figure 2. A photomicrograph illustrating a quail embryo at stage 25 (Hamburger and 
Hamilton, 1951), pinned down on to a black wax dish subsequent to the removal of the 
surrounding membranes. Stereomicroscopy. 60X 
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Figure 3. A photomicrograph illustrating the gastrointestinal tube (GT) of a stage 25 quail 
embryo (Hamburger and Hamilton, 1951), subsequent to the removal of the lateral body 
walls. Also shown are the heart (H), stomach (S) and liver (L). Stereomicroscopy. 60X. 
 
Figure 4. A photomicrograph illustrating the exposure of the pancreas (P), evaginated 
from the gastrointestinal tube (GT) of a stage 25 quail embryo (Hamburger and Hamilton, 
1951). The stomach (S), retracted to the left, and the heart (H) are also seen. 
Stereomicroscopy.  60X. (Courtesy of Roxanne Klopper) 
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Figure 5. A photomicrograph illustrating pancreatic mesoderm (white arrow), 
microdissected off the endoderm. Stereomicroscopy. 60X. (Courtesy of Roxanne 
Klopper) 
 
Figure 6. A representative photomicrograph of normal rat liver illustrating the hepatic 
architecture as viewed using light microscopy. Cords of hepatocytes constitute the bulk of 
the tissue, radiating outward from the central vein toward the portal tracts (PT). Sections 
(8µm) were stained with haematoxylin and eosin. 100X. 
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Figure 7. A representative photomicrograph of normal rat liver illustrating hepatic 
architecture as viewed using light microscopy. The polygonal shape of hepatocytes can 
be noted as well as their arrangement into plates. These plates form the boundaries of the 
hepatic sinusoids (black arrow). Hepatocyte nuclei vary in size, exhibiting clumps of 
heterochromatin. A bile duct (B) and arteriole (A), constituents of the portal tract, are 
illustrated. Sections (8µm) were stained with haematoxylin and eosin. 400X. 
 
Figure 8. A representative photomicrograph of rat liver treated with 40mg GaIN/100g 
body weight over a 4 day period. A portal tract (PT) is shown. The liver architecture does 
not differ markedly from that of normal liver illustrated in Figure 6. Hepatocyte cord 
structure does not appear to be adversely affected. Sections (8µm) were stained with 
haematoxylin and eosin. 100X. 
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Figure 9. A representative photomicrograph of rat liver treated with 40mg GaIN/100g 
body weight over a 4 day period, illustrating Figure 8 at higher magnification. A bile duct 
(B) and arteriole (A) have been included in the section. The arrangement of hepatocytes 
into plates can still be seen and no necrosis of the hepatic tissue is immediately evident.  
A few proliferating oval cells from areas closely associated with the bile duct can be 
seen. These cells, identified by the oval, palely basophilic nuclei (white arrow), have not, 
however, invaded the parenchyma. Sections (8µm) were stained with haematoxylin and 
eosin. 400X. 
 
Figure 10. A representative photomicrograph of rat liver treated with 50mg GaIN/100g 
body weight over a 5 day period. When compared to Figure 6, the hepatic structure 
illustrated in Figure 10 appears disorganized. The radial pattern of the hepatic cords has 
been disrupted compared to that of the untreated liver (Figure 6) and the liver treated with 
40mg GaIN/100g body weight over a 4 day period (Figure 8). Scattered areas of 
eosinophilia (white arrows), reflecting hepatocyte degeneration, were noted. Sections 
(8µm) were stained with haematoxylin and eosin. 100X. 
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Figure 11. A representative photomicrograph of rat liver treated with 50mg GaIN/100g 
body weight with a duration of hepatic injury over 5 days. At an increased magnification, 
hepatocyte plate structure as well as cord structure is seen to be disorganized. A bile duct 
(B) and arteriole (A) are indicative of the position of the portal tract. As illustrated in 
liver treated with 40mg GaiN over a 4 day period (Figure 9), oval cells exhibiting palely 
basophilic, oval nuclei and scant basophilic cytoplasm (white arrow), remain closely 
associated with the bile duct.  No oval cells are seen invading the surrounding 
parenchyma. An inflammatory response (black arrow) can also be seen. The leukocytes 
appear as small cells with darkly stained nuclei. Sections (8µm) were stained with 
haematoxylin and eosin. 400X. 
 
Figure 12. A representative photomicrograph of rat liver treated with 70mg GaIN/100g 
body weight over a 4 day period. A portal tract containing a venule (V), arteriole (A) and 
bile duct (B), is indicated. The hepatic architecture shows severe disruption with loss of 
hepatocyte cord structure resulting in a disorganized pattern. Sinusoidal dilation and areas 
of increased eosinophlia (white arrows), signifying hepatocyte degeneration, were also 
evident. Sections (8µm) were stained with haematoxylin and eosin. 100X.   
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Figure 13. A representative photomicrograph of rat liver treated with 70mg GaIN/100g 
body weight over a 4 day period. A venule (V) and bile duct (B) are illustrated in this 
micrograph. Proliferation of oval cells (long white arrow), recognized by their small size, 
elongated shape and palely basophilic oval nuclei, can be seen. These cells have invaded 
the parenchyma (long white arrow) and have also formed atypical ducts (short white 
arrow).  An intense inflammatory response, as evidenced by the presence of small cells 
exhibiting darkly stained nuclei (black arrow), is also indicated. Sections (8µm) were 
stained with haematoxylin and eosin. 400X. 
 
Figure 14. A representative photomicrograph of rat liver treated with 70mg GaIN/100g 
body weight with a 4 day duration of hepatic injury. Rows of oval cells, exhibiting palely 
basophilic nuclei and scant basophilic cytoplasm, are seen to have invaded the 
parenchyma (white arrows). Hepatic sinusoids (short black arrows) appear dilated, while 
complete disruption of the hepatic cords has occurred. Hepatocyte arrangement has 
assumed an acinar form. Acidophilic bodies are demonstrated (long black arrows). These 
are indicative of hepatocyte degeneration, evidenced by the loss of nuclear structure and 
the increase in cytoplasmic eosinophilia exhibited by a number of cells. Sections (8µm) 
were stained with haematoxylin and eosin. 400X. 
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Figure 15. A representative photomicrograph of rat liver treated with 70mg GaIN/100g 
body weight with a 5 day duration of hepatic injury. Hepatocyte cord structure, as 
exhibited in normal liver (Figure 6), has been lost. The parenchyma exhibits scattered 
areas of intense eosinophilia, associated with hepatocyte degeneration (white arrows), as 
well as sinusoidal dilation (black arrows). A portal triad (PT) has been included in the 
section. Sections (8µm) were stained with haematoxylin and eosin. 100X. 
 
Figure 16. A representative photomicrograph of rat liver treated with 70mg GaIN/100g 
body weight over a 5 day period. A venule (V), arteriole (A) and bile ducts (B) are 
indicated. Oval cells are identified by their palely basophilic small, oval nuclei and have 
come to line the bile ducts (white arrows). Acidophilic bodies (long black arrows) persist 
with a number of other hepatocytes also showing signs of degeneration. Leukocytes 
exhibiting small darkly stained nuclei, are prominent (short black arrows). Sections 
(8µm) were stained with haematoxylin and eosin. 400X. 
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Figure 17. A representative photomicrograph of rat liver treated with 70mg GaIN/100g 
body weight with a 5 day duration of hepatic injury illustrating the liver parenchyma. 
Hepatocyte cord structure has been lost, with the hepatocytes appearing to form acini. 
Sinusoidal dilation (short black arrow) is evident. Degenerating hepatocytes exhibiting 
intensely eosinophilic cytoplasm and destruction of nuclear structure are demonstrated 
(long black arrows). Cords of oval cells (long white arrow) are noted as well as the 
formation of atypical ductular structures by these cells (short white arrows).  Sections 
(8µm) were stained with haematoxylin and eosin.  400X. 
 
Figure 18. A photomicrograph illustrating PHeSC-A2 cells in the PDL-NAIR-1 culture 
system, 1 day post-seeding. The cells have adhered to the substrate and assumed a stellate 
morphology. Phase contrast microscopy. 200X. 
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Figure 19. A photomicrograph illustrating PHeSC-A2 cells in the PDL-NAIR-1 culture 
system, 3 days post-seeding. The cells have retained their stellate morphology and have 
proliferated, filling the spaces. Phase contrast microscopy. 200X. 
 
Figure 20. A photomicrograph illustrating the co-culture of PHeSC-A2 cells with quail 
pancreatic mesoderm in the GFRM-Hams F12.ITS system, on the second day of culture. 
The oval cells (C), were placed in close association with two pancreatic mesodermal 
explants (M). Proliferation of the mesodermal cells at the periphery of the explants is 
indicated (black arrows). Phase contrast microscopy. 40X. 
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Figure 21. A photomicrograph illustrating PHeSC-A2 cells and quail pancreatic 
mesodermal explants in the GFRM-Hams F12.ITS system, on day 4 of culture. Areas of 
proliferation of mesodermal cells can be seen (black arrow). Other areas of proliferation 
(white arrow) occur at the junction of mesoderm (M) and PHeSC-A2 cells (C) and it is 
unclear whether the former, latter or both components are undergoing proliferation. 
Furthermore, the oval cell area appears denser than that viewed on day 2 of culture 
(Figure 20). Phase contrast microscopy. 40X 
 
Figure 22. A photomicrograph illustrating the culture of PHeSC-A2 cells in GFRM-
Hams F12.ITS system without pancreatic mesoderm (control), on day 2 of culture. Cells 
(C) remained grouped together following seeding on to the substrate. This clustering 
contrasts with PHeSC-A2 cells grown in the PDL-NAIR 1 system (Figure 19). 
Proliferation of cells was not evident in the GFRM-Hams F12.ITS system. Phase 
contrast microscopy. 40X.  
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Figure 23. A photomicrograph illustrating the culture of PHeSC-A2 cells in GFRM-
Hams F12.ITS system without pancreatic mesoderm (control), on day 2 of culture. This 
illustrates Figure 22 at a higher magnification. A number of cells have clustered together 
(black arrow). Some cells have assumed a more spindle-shaped morphology (white 
arrow). This morphology is not comparable to PHeSC-A2 cells cultured in the PDL-
NAIR-1 system (Figure 19). Phase contrast microscopy. 400X. 
 
Figure 24. A photomicrograph illustrating PHeSC-A2 cells cultured on PDL-coated 
flasks using Hams F12.ITS (control). The morphology of these cells is visually similar 
to cells propagated in NAIR-1 medium (Figures 18 and 19). Phase contrast microscopy. 
40X. 
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Figure 25. A photomicrograph illustrating quail pancreatic mesoderm (M) cultured 
without oval cells in the GFRM-Hams F12.ITS system (control), on day1. Putative 
proliferation of mesodermal cells can be noted at the edges of the explant (arrow). 40X. 
 
Figure 26. A photomicrograph illustrating quail pancreatic mesoderm (M) cultured in the 
absence of oval cells in the GFRM-Hams F12.ITS system (control), on day 2 of culture. 
Mesodermal cells can be seen invading the surrounding GFRM, extending laterally 
(arrows). This may be due to both proliferation and dispersal of cells from the explant. 
Phase contrast microscopy.  40X. 
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Figure 27. A representative photomicrograph of the immunolocalization of glucagon 
conducted on serial sections of chick pancreatic control tissue. Glucagon-positive cells, 
visualised brown with DAB, are located toward the centre of the pancreatic islet. 
Differential interference contrast microscopy. 400X. 
 
Figure 28. This photomicrograph illustrates a negative control for glucagon localization 
conducted on serial sections of PHeSC-A2 and quail mesoderm co-cultures (See Figure 
37 for immunolocalization of glucagon in adjacent section). No immunolocalization of 
glucagon is exhibited since the secondary antibody was omitted and replaced with Tris-
saline buffer. Furthermore, no non-specific staining or background staining is evident. 
Differential interference contrast microscopy. 400X. 
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Figure 29. A photomicrograph illustrating an absorption control for glucagon localization 
in chick pancreatic tissue. No glucagon localization is evident since the glucagon 
antibody and its respective antigen were preabsorbed prior to the commencement of the 
ICC protocol. Differential interference contrast microscopy. 400X. 
 
Figure 30. A representative photomicrograph demonstrating immunolocalization of 
insulin conducted on serial sections of chick pancreatic tissue. Insulin-positive cells, 
visualised brown with DAB, are confined to the pancreatic islets, more specifically, to the 
periphery of those islets. Differential interference contrast microscopy. 400X. 
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Figure 31. This photomicrograph illustrates a negative control for insulin localization 
conducted on adjacent sections of PHeSC-A2 and quail pancreatic mesoderm co-cultures 
(See Figures 35 for immunolocalization of insulin in adjacent section). No localization of 
insulin is evident since the secondary antibody was omitted and replaced with Tris-saline 
buffer. Differential interference contrast microscopy. 400X. 
 
Figure 32. A representative photomicrograph demonstrating an absorption control for the 
immunolocalization of insulin in chick pancreatic tissue. The insulin antibody was 
preabsorbed with its respective antigen overnight, prior to commencement of the ICC 
technique. No immunolocalization of insulin was thus evident. Differential interference 
contrast microscopy. 400X. 
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Figure 33. A photomicrograph illustrating quail mesodermal cells exhibiting a light 
background stain with DAB. Quail cells are easily distinguished by their large clear 
nuclei and prominent nucleoli (arrows). No insulin immunolocalization is exhibited, 
contrasting with insulin positive cells in chick pancreatic tissue as demonstrated in Figure 
30. Differential interference contrast microscopy. 1000X.  
 
Figure 34. A photomicrograph demonstrating the immunolocalization of insulin in 
PHeSC-A2 and quail pancreatic mesoderm co-cultures. Granules evident in the 
cytoplasm of insulin-positive cells are highlighted (arrows). These cells contrast 
dramatically with those of the quail mesodermal cells seen in Figure 33. It is thus 
proposed that the insulin-positive cells were derived from PHeSC-A2 cells. Differential 
interference contrast microscopy. 1000X. 
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Figure 35. This photomicrograph illustrates a PHeSC-A2 and quail pancreatic mesoderm 
co-culture. Slight background staining is apparent in the GFRM (white arrow). 
Immunolocalization of two insulin-positive cells is evident (black arrows). Cell nuclei, 
seen as raised structures, are small and oval. The surrounding cytoplasm appears 
granular. This is indicative of insulin cells, moreover, their morphology when contrasted 
to quail mesodermal cells (Figure 33) implicates their origin from PHeSC-A2 cells. 
Differential interference contrast microscopy. 400X. 
 
Figure 36. This photomicrograph illustrates insulin immunolocalization in a PHeSC-A2 
and quail pancreatic mesoderm co-culture. Clusters of cells (black arrows) are visualised 
brown with DAB, indicating insulin-positive cells. Cell nuclei appear as small, oval, 
raised structures. The cytoplasm is granular. Since their morphology contrasts with that 
of quail mesodermal cells (Figure 33), it is proposed that these insulin-positive cells are 
derived from PHeSC-A2 cells. Differential interference contrast microscopy. 400X. 
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Figure 37. A representative photomicrograph demonstrating immunolocalization of 
glucagon in a PHeSC-A2 and quail mesoderm co-culture. Two cells presenting with 
darkly staining oval nuclei and granular cytoplasm are demonstrated. This morphology 
indicates glucagon-positive cells as well as their derivation from PHeSC-A2 cells when 
compared with the quail cells seen in Figure 33.  Differential interference contrast 
microscopy. 1000X. 
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1 
INTRODUCTION 
 
Diabetes mellitus is a metabolic disorder affecting more than 120 million people 
worldwide  a number expected to increase to 300 million over the ensuing two decades 
(Horb et al., 2003). This illness is characterized by chronic hyperglycaemia, attributable 
to an insulin deficiency, insulin resistance or a combined effect. Insulin is a hormone 
secreted by β-cells within the pancreatic islets and is essential for glucose homeostasis 
(Horb et al., 2003). The modulation of blood-glucose levels exists as an inverse 
relationship between the amount of glucose released by the liver and the amount of 
insulin produced by the pancreas. Blood-glucose levels, despite variations in food uptake, 
fasting and the utilization of glucose, are normally maintained within the range of 3.5-
8.0mmol/L (Gale and Anderson, 2002).  During periods of fasting, low levels of insulin 
act to modulate the amount of glucose released by the hepatic processes of 
glycogenolysis and gluconeogenesis. Postprandial, insulin levels increase, thereby 
suppressing the release of glucose from the liver and promoting the uptake of circulating 
glucose by fat and muscle (Gale and Anderson, 2002).  
 
Diabetes mellitus presents itself in two forms: type I and type II. Although clinical 
symptoms may overlap, the epidemiology and aetiology of the two diseases differ. Type I 
diabetes is foremost a childhood disease, peaking in incidence at adolescence. It occurs 
primarily in Western countries, in individuals of European ancestry. Type I diabetes is 
not genetically predetermined; however, a definite polygenic susceptibility to the disease 
has been identified (Gale and Anderson, 2002). This susceptibility presents as specific 
variations of the polymorphic HLA genes that are responsible for the regulation of the 
immune system. Autoantibodies are directed against the insulin-producing cells of the 
pancreas. The presence of these autoantibodies in serum predates the clinical onset of the 
disease significantly. Type I diabetics thus suffer from progressive loss of β-cell structure 
and function, leading to an insulin-dependency (Stephenson, 2002). 
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Type II diabetes presents in all population groups with varying degrees of prevalence and 
is lowest in individuals of European ancestry. This disease is associated with the 
westernization of certain population groups, affluent living conditions and sedentary 
lifestyles. Incidence of type II diabetes increases markedly with age and obesity (Gale 
and Anderson, 2002). Although a clear pattern of inheritance has yet to be elucidated, a 
genetic component to this disease has been confirmed (Stephenson, 2002). However, 
unlike type I diabetes there is no involvement of the HLA genes. Type II diabetes is not 
an immune-mediated disease and only half of all sufferers progress to total insulin-
dependency (Gale and Anderson, 2002). Factors in the pathogenesis of type II diabetes 
include insulin resistance as well as depletion of the β-cell population. Although insulin is 
able to bind to its cell surface receptor, genetic abnormalities disrupt the signaling 
pathway within the cell prohibiting insulin function, a phenomenon described as insulin 
resistance. Furthermore, the loss of β-cell mass, although not as significant as presented 
in type I diabetes, is sufficiently marked to disrupt glucose homeostasis (Gale and 
Anderson, 2002).  
 
Without appropriate intervention, diabetes mellitus is a potentially fatal disease. 
Furthermore, despite that intervention, the cardiovascular, renal and nervous system may 
be affected, reducing life expectancy by almost a third (Montague, 1983). To date no cure 
for diabetes has been found, but a form of diabetes therapy has been postulated. 
Pancreatic islet transplantation has been reported to be successful (Lechner and Habenar, 
2003), but presents problems both of immune rejection and donor supply (Horb et al., 
2003). An alternative proposition is the acquisition of adult stem cells from biopsy 
samples and the differentiation thereof into insulin-producing cells prior to 
transplantation. Such treatment would preclude problems of availability and rejection 
(Burns et al., 2004). The use of adult hepatic stem cells for the treatment of diabetes, 
based both on the close embryological association of the pancreas and liver, and on the 
possibility of a shared tissue stem cell, has been proposed (Dabeva et al., 1997).  
 
Embryologically, the pancreas and liver develop from adjacent areas of the primitive gut 
(Yang et al., 2002). During the process of gastrulation, the trilaminar embryonic disc 
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commences folding in the median and horizontal planes, creating a cylindrical embryo. 
The inclusion of the endodermal component of the dorsal aspect of the yolk sac during 
this folding forms the primitive gut which is divided into three parts: the foregut, midgut 
and hindgut (Allan and Kramer, 2002).  
 
At this stage hepatic and ventral pancreatic cells are specified in the ventral foregut 
endoderm, while cells for the dorsal pancreas are specified in the middle and dorsal 
portions of the foregut endoderm (Yoshitoma and Zaret, 2004). Recent research has 
shown that both the dorsal and ventral regions of foregut endoderm are committed to a 
pancreatic fate as early as the 8-somite stage in the mouse model (Yoshitoma and Zaret, 
2004). This contrasts dramatically with the competency of ventral foregut endoderm in 
hepatogenesis (Hogan and Zaret, 2002). Studies have shown that only the anterior portion 
of the ventral foregut endoderm is capable of producing completely competent 
hepatocytes just prior to the evagination of the hepatic diverticulum (Hogan and Zaret, 
2002).  
 
It has been postulated that despite the variable array of gene expression present within the 
endoderm, the differentiation capacity of this germ layer is predominantly controlled by 
signals from the overlying mesoderm (Yoshitoma and Zaret, 2004). The regions of 
foregut endoderm essential to hepatic and pancreatic development are exposed to a large 
mesodermal contingent including the septum transversum  an accumulation of 
mesoderm situated between the developing heart and midgut, and the notochord (Moore 
and Persaud, 1998; Allan and Kramer, 2002). Furthermore, it has been established that 
differentiation of the liver is dependant on interactions of the hepatic diverticulum with 
cardiogenic mesoderm via the septum transversum, without which the endoderm reverts 
to a pancreatic fate (Moore and Persaud, 1998; Kumar et al., 2003; Yoshitoma and Zaret, 
2004). This highlights the possibility that liver and pancreas progenitor cells specified in 
the endoderm maintain a level of plasticity enabling them to act as bipotential precursors 
with a pre-pattern that allows for the induction of either hepatic or pancreatic fates, 
dependant on particular mesodermal influences. 
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The pancreas and liver also share phenotype-maintaining transcription factors, for 
example HNF transcription factors (Odom et al., 2004), as well as roles in the regulation 
of glucose homeostasis (Burns et al., 2004). In light of their common embryological 
origin, elucidated in the preceding paragraphs, it has been postulated that the two adult 
organs retain a common progenitor cell (Dabeva et al., 1997). Progenitor cells, also 
known as transit-amplifying cells, are the progeny of stem cells residing within adult 
tissues and act as intermediaries between the tissue stem cell and terminally differentiated 
cells (Sell, 2004).  
 
A stem cell is characterized by its potential to differentiate into a number of cell types 
(Preston et al., 2003).  The primordial stem cell, the fertilized ovum, is totipotent  
capable of differentiating into all cell lineages of the organism in question. On cleavage, 
via a process of synchronous division, the egg gives rise to daughter cells that are 
identical in every aspect including totipotentiality (Sell, 2004). However, an inverse 
relationship exists between the potentiality of a stem cell and the acquisition of 
specialized function. As the zygote develops, cells undergo the process of determination 
where they become committed to certain cell fates and in doing so, limit their potential. 
The resulting multipotential stem cells of the trilaminar embryo in turn give rise to stem 
cells whose potential is postulated to be further limited. These stem cells, known as tissue 
stem cells, reside within the organs and are said to persist  to adulthood (Sell, 2004).  
 
Tissue stem cells give rise to progenitor cells, which act not only to produce committed 
cells capable of specific duties, but also to maintain their own populations. This is 
accomplished through a process of asymmetric division whereby the progenitor cell 
divides allowing one daughter cell to approach commitment and the other to retain its 
potential (Preston et al., 2003; Sell, 2004). It can therefore be expected that a tissue may 
contain stem cells in differing states of potential  from multipotentiality to 
unipotentiality. 
  
Hepatic stem cells were first identified in early cancer research (Petersen, 2001). 
However, the existence of such a population became the subject of much controversy due 
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to the livers inherent ability to reconstitute its mass via the division of mature 
hepatocytes, independent of the involvement of putative stem cells (Sell, 2004). A 
number of studies have nonetheless demonstrated that when the liver is placed under 
stress considerable enough to impede the regenerative capacity of hepatocytes, the 
hepatic stem cell niche is activated. Differentiation of these stem cells into progenitor 
cells termed oval cells allows for the restoration of the hepatic parenchyma (Sell, 2004). 
 
Hepatocellular injury and subsequent oval cell activation has been achieved using a 
number of carcinogenic and non-carcinogenic models. These include the use of 
acetylamino fluorene (AAF) followed by partial hepatectomy (Evarts et al., 1989), the 
administration of carbon tetrachloride (CCl4) (Gil-Benso et al., 2001) and d-
galactosamine (GaIN) (Dabeva and Shafritz, 1993). 
 
The source of oval cells remains a controversial subject. A number of studies postulate 
the derivation of oval cells from tissue stem cells residing within the canals of Hering 
(Germain et al., 1988; Wang et al., 2003). Other studies argue an extrahepatic source of 
oval cells  bone marrow  and propose the canals of Hering as a transitional 
compartment within which differentiation along a hepatic lineage occurs (Petersen, 
2001).   Such disparity is reflected in the characteristics of oval cells themselves. These 
progenitor cells express markers for both cell types of the hepatic lineage, CK19 for 
biliary epithelium and albumin for hepatocytes, as well as the immature liver cell markers 
α-fetoprotein (AFP) and λ-glutamyl transpeptidase (GGT) (Lemire et al., 1991; Wang et 
al., 2003). Interestingly they also express the haematopoietic stem cell markers CD34, 
CD90 (Thy1) and c-kit (Alison and Sarraf, 1998).  
 
Although traditionally regarded as bipotential stem cells confined to the limits of the 
hepatic lineage, oval cells have been shown to differentiate into tissue other than liver, 
notably, pancreatic endocrine cells. Oval cells cultured in the absence of LIF (a factor 
capable of inhibiting stem cell differentiation) and in the presence of high glucose 
concentrations, are able to differentiate into insulin-producing β-cells (Yang et al., 2002). 
Furthermore, the induction of PDX1 expression via gene transfection protocols in hepatic 
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progenitor cells has been shown to cause the differentiation of hepatic progenitor cells 
into insulin-producing cells (Nakajima-Nagata et al., 2004).  
 
Such research may merely propose a revisitation to the claimed bipotentiality of the oval 
cell, or may have deeper implications  that of highlighting the close association of the 
pancreas and liver and the affirmation of the existence of a hepatopancreatic stem cell. A 
number of studies have indicated that oval cells are not restricted to the liver, but 
astonishingly, have been identified in the pancreas of several mammalian models 
(Grompe, 2003).  
 
Rats maintained on a copper-deficient diet for eight weeks presented with marked 
destruction of pancreatic acinar tissue with no involvement of either the pancreatic ducts 
or islets of Langherhans  (Rao et al., 1989). During this period, cells with characteristics 
of oval cells appeared within the pancreatic tissue. On the re-introduction of copper to the 
diet, these putative oval cells differentiated into hepatocytes (Rao et al., 1989). 
Furthermore, hepatocytes derived from pancreatic oval cells are indistinguishable from 
those derived from hepatic oval cells, phenotypically and functionally (Dabeva et al., 
1997; Grompe, 2003). Pancreatic cell phenotypes have also been detected in the liver, 
specifically in cases of cholangiocarcinoma, in which hepatic oval cell involvement is 
also implicated (Petersen, 2001; Grompe, 2003). Several studies have proposed that 
pancreatic progenitor cells have a differentiation capacity restricted to that of the 
pancreatic lineage (Soria et al., 2005). However, studies conducted by Suzuki et al. 
(2004) have identified the expression of hepatocyte growth factor (HGF) in pancreatic 
progenitor cells. Furthermore, pancreatic progenitor cells, expressing the neural-stem cell 
specific marker, nestin, have been shown to differentiate into cells expressing hepatic 
phenotypes (Zulewski et al., 2001).  
 
Although further characterization of both pancreatic and hepatic stem cells is needed, the 
highlighted studies validate the hypothesis of a hepatopancreatic stem cell. The role of 
mesodermal influences and the elucidation of the factors involved in the specification of 
the pancreatic and hepatic cell lineages are also in need of further exploration. This study 
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therefore aimed to investigate whether hepatic oval cells have the capacity to differentiate 
into pancreatic β-cells under the influence of pancreatic mesoderm in an in vitro system.  
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2 
MATERIALS AND METHODS 
 
All animals used in these experiments were obtained from the Central Animal Services, 
University of the Witwatersrand. Animal ethics clearance was obtained (AEC Number: 
2004/39/3 and 2006/69/3) and is applicable to both Sprague Dawley rats and fertile quail 
eggs. 
 
2.1 ISOLATION OF OVAL CELLS 
2.1.1 Determination of appropriate GaIN dosage and duration of hepatic injury 
Male Sprague Dawley rats within the weight range 240g-340g were initially injected, 
intraperitoneally, with various doses of GaIN (Sigma-Aldrich, SA), ranging between 
40mg and 70mg GaIN/100g body weight in 1ml 0.14M NaCl, to determine whether the 
extent of hepatic injury was sufficient to induce oval cell proliferation. GaIN concentrates 
were prepared in sterile saline and filtered prior to use. Animals were killed either 4 or 5 
days following GaIN administration to test whether the duration of hepatic injury 
impacted on the size of the oval cell population induced. Furthermore, animals injected 
with 1ml 0.14M NaCl only, served as normal controls with which to compare the GaIN-
treated hepatic tissue. 
 
Following hepatic injury animals were killed with an overdose of Euthanase (Centaur 
Labs, USA) via an intraperitoneal injection. Pieces of liver were removed, fixed in 10% 
buffered formalin and processed through a series of alcohols and chloroform overnight. 
Tissue was embedded in paraffin wax and 8µm sections were cut and stained using 
haematoxylin and eosin for histological analysis. Based on the results obtained as well as 
literature citations (Lemire et al., 1991; Dabeva and Shafritz, 1993), the GaIN dosage was 
established at 70mg GaIN/100g body weight and the duration of hepatic injury, at 5 days 
post-GaIN administration.  
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2.1.2 Termination of animals and sorting of oval cells 
Animals were anaesthetized with a weight-dependant dose of ketamine and rompin (4:1).  
Prior to the opening of the abdominal cavity, the abdomen was shaved and swabbed with 
70% alcohol. Thereafter, experimental procedures were conducted under a laminar flow 
hood in sterile conditions.  In order to perfuse the liver and cause dissociation of tissue, 
the aorta was tied off, the portal vein cut and approximately 20ml 0.05% TypeVIII 
collagenase (Sigma-Aldrich, SA) in IMDM (Sigma-Aldrich, SA) was injected into the 
inferior vena cava and allowed to circulate for 5 minutes. 
 
Liver lobes were removed, rinsed in PBS and placed in 0.05% collagenase for 15 
minutes. The tissue was then chopped with a fine blade and pressed through a fine wire 
mesh in order to obtain a single cell suspension. Three different methods of cell sorting 
were used to elucidate an oval cell fraction: 
 
2.1.2.1 Cell sorting with MiniMACS kit: Direct Labelling 
Briefly, the MiniMACS kit (Miltenyi Biotec, Germany) incorporates magnetic 
cell separation technology. Desired antigens may be either directly or indirectly 
labelled, as per normal immuncytochemistry principles, with magnetic 
microbeads. Labelled single cell suspensions are passed through a separation 
column which is placed within a powerful magnetic field. Thus, magnetically 
labeled cells from the suspension adhere to the column allowing the unlabelled 
fraction to pass through. Labelled cells are then collected by removing the 
separation column from the effects of the magnet and flushing out the cells. The 
procedure for direct labeling is as follows: 
 
The cell suspension was washed in degassed phosphate buffered saline (PBS) (see 
Appendix I) supplemented with 2mM ethylenediaminetetraacetic acid (EDTA) 
(Sigma-Aldrich, SA) and 0.5% bovine serum albumin (BSA) (Sigma-Aldrich, 
SA) at pH7.2, and centrifuged at 400g for 5 minutes. The cell pellet was 
resuspended in 90µl of buffer, to which 10µl of mouse CD90 magnetic 
microbeads (Miltenyi Biotec, Germany) were added. The solution was incubated 
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at 7ºC for 15 minutes. Thereafter, cells were washed with buffer and centrifuged 
at 300g for 10 minutes. The supernatant was removed and the pellet resuspended 
in 500µl of buffer.  
 
In order to separate the unlabelled from the labeled fraction, the cell suspension 
was applied to a MACS separation column, attached to a powerful magnetic 
separator. The unlabelled fraction was allowed to pass through and discarded. The 
separation column was then removed from the separator and the labelled fraction 
flushed out into an eppendorf.  
 
The labelled fraction was then seeded on to fibronectin-coated Nunc Wells (Nunc, 
Denmark) and grown in Iscoves Modified Dulbeccos Medium (IMDM) 
supplemented with 10ng/ml stem cell factor (SCF) (Santa Cruz, USA), 10ng/ml 
leukaemia inhibitory factor (LIF) (Santa Cruz, USA), 10ng/ml Flt-3 ligand (Santa 
Cruz, USA) and 1µl/ml penicillin-streptomycin (Yang et al., 2002). Cells were 
maintained in culture at 37 ºC with 5% CO2 in air, in a humidified environment. 
 
2.1.2.2 Cell sorting with MiniMACS kit: Indirect Labelling 
Indirect labeling follows the same principle of magnetic cell sorting as elucidated 
in 2.1.2.1., the only difference being the use of a flurochrome-conjugated primary 
antibody. In doing so, this method precludes problems of magnetic microbead 
specificity by allowing the use of more specific antibodies. The antibody is 
directed against the antigen of interest whilst the magnetic microbeads are 
directed against the flurochrome conjugated to the antibody itself. Indirect 
labeling of cells proceeds as follows: 
 
The cell suspension was centrifuged at 100g and the resulting pellet resuspended 
in 100µl degassed PBS buffer supplemented with 2mM EDTA and 0.5% fetal calf 
serum (FCS) (Highveld Biological, SA). Cells were labeled with 10µl CD90 
phycoerythrin (PE)-conjugated antibody (US Biological, USA) and incubated in 
the dark at 7ºC for 10 minutes. Cells were washed in 1ml buffer and centrifuged at 
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300g for 10minutes. The supernatant was removed and the cell pellet resuspended 
in 80µl buffer. The suspension was incubated at 7 ºC for 15 minutes with 20µl 
Anti-PE Microbeads (Miltenyi Biotec, Germany).  
 
Cells were washed further by adding 1ml buffer and centrifuging at 300g for 
10minutes. The pellet was resuspended in 500µl buffer and applied to a MACS 
separation column. The unlabelled fraction was allowed to pass through. The 
column was then removed from the magnetic separator and the labeled fraction 
flushed out with 500µl buffer.  
 
The labeled fraction was seeded onto poly-d-lysine (PDL) (Sigma-Aldrich, USA) 
coated flasks and grown in IMDM supplemented with SCF (10ng/ml), LIF 
(10ng/ml), Flt-3 ligand (10ng/ml) (Yang et al., 2002) and penicillin-streptomycin 
(1µl/ml). Cells were cultured in a humidified environment at 37 ºC with 5% CO2 
in air. 
 
2.1.2.3 Cell sorting as adapted from Kano et al.(2003) 
The single cell suspension as obtained from methods elucidated in 2.1.2., was 
pipetted into centrifuge tubes and centrifuged at 60g for 2 minutes. The 
supernatant was removed, the cell pellet resuspended in PBS and centrifuged at 
350g for 5 minutes. Two further centrifugation steps ensued, the cell suspension 
being centrifuged twice at 60g for 75 seconds.  
 
The resulting cell pellet was seeded on to fibronectin (Sigma-Aldrich, USA) 
coated Ultra-Web Synthetic ECM (Donaldson, USA). These synthetic matrices, 
composed of nylon nanofibres, are designed to resemble the structure of basement 
membranes or extracellular matrix (ECM). Consequently, cells grown thereon 
assume phenotypes more similar to their in vivo morphology. The cell pellet once 
seeded, was left to adhere to the ECM for 30 minutes before the addition of 
IMDM supplemented with SCF (10ng/ml), LIF (10ng/ml), Flt-3 ligand (10ng/ml) 
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(Yang et al., 2002) and penicillin-streptomycin (1µl/ml). Cells were cultured in a 
humidified environment at 37 ºC with 5% CO2 in air. 
 
2.2 CULTURE OF HEPATIC STEM-LIKE CELL LINE (PHESC-A2) 
A porcine hepatic stem-like cell line (PHeSC-A2) was kindly donated by Prof. J. Kano 
(Department of Diagnostic Pathology, I.B.M.S., G.S.C.H.S., University of Tsukuba, 
Japan). PHeSC-A2 was propagated, under sterile conditions, on PDL-coated flasks in 
specifically formulated NAIR-1 medium (Highveld Biological, SA) (see Appendix I) 
with 1µl/ml penicillin-streptomycin (Kano et al., 2003). The cell line was maintained in a 
humidified environment with 5%CO2 in air at 37 ºC. When confluent, cells were treated 
with a solution of Trypsin-EDTA (Sigma-Aldrich, SA) to facilitate lifting and re-seeded 
in PDL-coated flasks. 
 
2.3 CO-CULTURE OF PHESC-A2 CELLS AND QUAIL PANCREATIC MESODERM 
All ensuing experimentation was conducted under sterile conditions within a laminar 
flow hood. 
 
2.3.1 Microdissection of mesoderm from quail pancreatic buds 
Fertile quail (Coturnix coturnix japonica) eggs were incubated in a humidified 
environment at 37ºC for 5 days to allow for development of the dorsal pancreatic bud. 
Embryos staged between 24-26 (Figure 1), according to Hamburger and Hamilton (1951), 
were pinned on to black wax dishes (Figure 2) in chick Ringers solution (see Appendix 
I), prior to the removal of the surrounding membranes.  The lateral body wall was 
removed exposing the underlying gut tube (Figure 3) which was dissected out and 
incubated in 0.04% TypeVIII collagenase (Sigma-Aldrich, SA) in Tyrodes solution (see 
Appendix I) at 20ºC for 20 minutes. Thereafter, utilizing transmitted and incident light, 
the pancreatic mesoderm was microdissected from the endoderm of the dorsal pancreatic 
bud (Figures 4 and 5) and left in Tyrodes solution at 37ºC until use.  
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2.3.2 Culturing of PHeSC-A2 cells and quail pancreatic mesoderm in the GFRM-
Hams F12.ITS system 
A solution of Trypsin-EDTA was applied to a flask of near confluent PHeSC-A2 cells in 
order to lift them. The suspension was centrifuged at 100g for 5 minutes and the 
supernatant removed. 1µl of NAIR-1 medium was applied to the pellet. Thereafter, cells 
were pipetted directly on to polymerized growth factor-reduced Matrigel (GFRM) (BD 
Biosciences, USA), a biologically active matrix resembling in vivo basement membrane, 
and incubated at 37ºC for 30 minutes allowing the cells to adhere to the substrate. 
Subsequently, quail mesoderm was placed on to the cell aggregations and more cells 
pipetted on and around the explants. A final layer of GFRM was laid down over the 
PHeSC-A2 and mesoderm co-culture and left to polymerize at 37ºC for 30 minutes prior 
to the addition of Hams F12.ITS medium containing additional insulin, transferrin and 
selenium (Highveld Biological, SA). The culture was maintained for 5 days at 37ºC in a 
humidified incubator in 5% CO2 in air. 
 
2.3.2.1 Control: Culturing of PHeSC-A2 cells in the GFRM-Hams F12.ITS system 
without pancreatic mesoderm 
Subsequent to the trypsinization and centrifugation steps as elucidated above, 
PHeSC-A2 cells were pipetted on to polymerized GFRM. The cells were covered 
with a further layer of GFRM which was allowed to polymerize prior to the 
addition of Hams F12.ITS medium. These cells were cultured in the absence of 
quail pancreatic mesoderm for 5 days at 37ºC in a humidified incubator in 5%CO2 
in air. This experiment was carried out to visually assess the behaviour and 
morphology of PHeSC-A2 cells in the GFRM-Hams F12.ITS system. 
 
2.3.2.2 Control: Culturing of quail pancreatic mesoderm in the GFRM-Hams F12.ITS 
system without PHeSC-A2 cells 
Quail pancreatic mesoderm was laid down on to polymerized GFRM and 
subsequently covered with a layer of GFRM. The mesoderm explant was 
maintained in culture, in Hams F12.ITS medium, for 5 days at 37ºC in a 
humidified incubator in 5% CO2 in air. This experiment was conducted to visually 
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assess the proliferation of mesodermal cells and to provide a positive control for 
the immunolocalization of the quail nuclear marker (see 2.4.3.). 
  
2.3.2.3 Control: Culturing of PHeSC-A2 cells in the PDL-Hams F12.ITS system 
A solution of Trypsin-EDTA was applied to a flask of PHeSC-A2 cells in order to 
detach the cells from the PDL substrate. The resultant suspension was centrifuged, 
washed in PBS and replated on to PDL-coated flasks. The cells were cultured in 
Hams F12.ITS medium, in order to visually assess differences in structure when 
compared to those grown in the PDL-NAIR-1 system. 
 
 
2.4 IMMUNOCYTOCHEMISTRY 
2.4.1 Immunolocalization of AFP (an oval cell marker) in PHeSC-A2 cells 
PHeSC-A2 cells were grown to near confluency prior to processing for 
immunocytochemistry. All processing procedures were carried out within the flask itself. 
Medium was poured off and cells washed in PBS (pH7.4). Cells were fixed in 2.5% 
glutaraldehyde in 1M PBS (pH7.4) at 4ºC for 1 hour followed by rinsing in PBS. 
Thereafter, they were dehydrated through a graded series of alcohols for 10 minutes at 
each percentage. The monolayer was thereafter infiltrated with Epon-Araldite resin (1:1) 
in ethanol and 2 changes of 100% for 10 minutes consecutively. Cells were then covered 
with a thin layer of Epon-Araldite resin (1:1).  
 
The flask was left open and incubated at 60ºC to allow the resin to polymerize. The 
following day, the flask was broken open and the layer of resin removed. Strips were cut 
and placed into a rubber mould. Epon-Araldite resin (1:1) was poured into the moulds 
and left to polymerize again at 60ºC for 24 hours. Serial 1µm sections were cut for 
immunolocalization of AFP.  
 
Sections were deplasticised in sodium ethoxide diluted 1:2 with absolute alcohol for 10 
minutes. They were washed in absolute alcohol and hydrated through 95% alcohol to 
distilled water. Sections were washed in PBS and blocked in 10% rabbit serum in PBS 
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for 20 minutes. Primary antibody, goat polyclonal AFP (Santa Cruz, USA) diluted 1:500 
in PBS supplemented with 1.5% BSA, was applied to sections and incubated at room 
temperature for an hour. Sections were washed in three changes of PBS for 5 minutes 
each. They were then incubated with a rhodamine-conjugated rabbit anti-goat secondary 
antibody (Santa Cruz, USA), diluted 1-5µg/ml, for 45 minutes. Following washing in 
PBS, sections were mounted with VectaShield Mounting Medium (Vectorlabs, USA).  
 
2.4.1.1 Controls for the immunolocalization of AFP in PHeSC-A2 cells 
Positive controls were used to determine the efficacy of the technique. A tissue 
sample in which AFP is a known component was used as a positive control for the 
oval cell marker AFP. Fourteen and a half day-old mouse fetal liver was quenched 
in chilled isopentane prior to being freeze-dried overnight at -40°C and 10-2 Torr. 
Tissue was then fixed in parabenzoquinone vapour for 3 hours at 60ºC, and 
infiltrated with Epon-Araldite resin (1:1) for 3 hours at 10-2 Torr. The resin was 
allowed to polymerize for 48 hours at 60°C. Serial 1µm sections were cut and 
deplasticized. ICC was conducted as per the experimental tissue procedure. 
Negative controls were conducted in which the primary and secondary antibodies 
were omitted and replaced with buffer.  
 
2.4.2 Immunolocalization of insulin and glucagon in PHeSC-A2 and quail pancreatic 
mesoderm co-cultures 
PHeSC-A2 and mesoderm co-cultures were dissected out of the GFRM and quenched in 
chilled isopentane. Tissue was freeze-dried overnight at -40°C and 10-2 Torr, fixed in 
parabenzoquinone vapour for 3 hours at 60ºC and infiltrated with Epon-Araldite resin 
(1:1) for 3 hours at 10-2 Torr. Tissue was embedded in resin which was allowed to 
polymerize for 48 hours at 60ºC. Serial 1µm sections were cut for routine histological 
examination with toluidine blue staining and immunolocalization of insulin and glucagon.  
 
Sections were deplasticised in sodium ethoxide diluted 1:2 with absolute alcohol for 
10minutes. They were washed in absolute alcohol, hydrated through 95% alcohol to 
distilled water and washed further in Tris/saline (see Appendix I). Slides were then 
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placed in 3% hydrogen peroxide in distilled water for 10 minutes and washed again in 
Tris/saline. They were then covered with 10% swine serum in Tris/saline for ten minutes 
in a damp chamber at room temperature. To detect insulin-producing cells, sections were 
incubated with guinea pig anti-insulin (Chemicon, USA) at 1:800 and for the detection of 
glucagon-producing cells sections were incubated with rabbit anti-glucagon (Euro 
Diagnostica, Sweden) at 1:1000, overnight. Both primary antibodies were diluted in 
Tris/saline. 
 
The following day, sections were washed in three changes of 1% horse serum in 
Tris/saline for 5 minutes each. They were thereafter incubated with secondary antibody:  
rabbit anti-guinea pig peroxidase (Dako, Denmark) and swine anti-rabbit peroxidase 
(Dako, Denmark) for insulin and glucagon-labeled cells respectively, for 1 hour at room 
temperature in a damp chamber. Both antibodies were used at a 1:20 dilution with a 
specific diluent (see Appendix I). Sections were washed in three changes of Tris/saline 
for 5 minutes each. Thereafter they were incubated in DAB (Sigma-Aldrich, SA) solution 
(see Appendix I) for 5 minutes to allow for visualization of the antigen-antibody 
complex. Sections were then washed in Tris/saline followed by distilled water and were 
then washed further for 5 minutes in gently running tap water. Sections were dehydrated 
through a graded series of alcohols, cleared in xylene and mounted in Entellen.  
 
2.4.2.1. Controls for the immunolocalization of insulin and glucagon 
Positive controls were used to determine the efficacy of the technique. A tissue 
sample in which insulin and glucagon are known components, was used. Resin-
embedded chick pancreas thus served as a control for both insulin and glucagon 
immunolocalization. ICC was conducted as above. Negative controls were 
conducted in which both primary and secondary antibodies for the insulin and 
glucagon immunocytochemical protocols, were omitted and replaced with buffer, 
thus prohibiting the formation of antigen-antibody complexes. Furthermore an 
absorption control was also carried out in which both primary antibodies were 
preabsorbed with their respective antigens overnight, prior to the execution of the 
ICC protocol, in order to ascertain the specificity of the antibodies in question.  
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2.4.3 Immunolocalization of the Quail Nuclear Marker 
PHeSC-A2 and pancreatic mesoderm co-cultures were dissected out of GFRM and 
quenched in chilled isopentane. Tissue was freeze-dried overnight at -40°C and 10-2 Torr, 
fixed in parabenzoquinone vapour for 3 hours at 60ºC and infiltrated with Epon-Araldite 
resin (1:1) for 3 hours at 10-2 Torr. Tissue was embedded in resin which was allowed to 
polymerize for 48 hours at 60ºC. Serial 1µm sections were cut for immunolocalization of 
the quail nucleus.  
 
Sections were deplasticised in sodium ethoxide diluted 1:2 with absolute alcohol for 
10minutes. They were washed in absolute alcohol, hydrated through 95% alcohol to 
distilled water and washed in PBS (see Appendix I). Sections were placed in 10% rabbit 
serum in PBS for 45 minutes followed by incubation with the quail cell nuclear marker, 
QCPN mAB (Sigma-Aldrich, SA), overnight at 4°C. The primary antibody was used 
undiluted. Sections were rinsed in PBS and incubated with a rabbit anti-mouse peroxidase 
conjugated secondary antibody (Dako, Denmark) for 1 hour. The secondary antibody was 
diluted in a ratio of 1:50 with PBS. DAB was then applied to the sections for 5 minutes 
prior to rinsing, to allow for visualization of the antigen-antibody complex. Sections were 
thereafter dehydrated through a series of alcohols, cleared in xylene and mounted in 
Entellen.  
 
2.4.3.1. Controls for the immunolocalization of the quail nuclear marker 
Positive controls conducted on quail pancreatic mesoderm, served to test the 
effectiveness of the ICC protocol. Immunolocalization of quail nuclei was conducted as 
stated in the preceding paragraphs. Nuclei were expected to be visualized as brown with 
DAB. Negative controls, in which the primary and secondary antibody was omitted and 
replaced with PBS prior to the continuation of the normal ICC technique as highlighted 
above, were intended to investigate the specificity of the primary antibody.  
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2.5.Identification of the Quail Nucleus using the Feulgen Method (Bancroft and Cook, 
1996) 
PHeSC-A2 and mesoderm co-cultures were dissected out of the GFRM and quenched in 
chilled isopentane. Tissue was freeze-dried overnight at -40°C and 10-2 Torr, fixed in 
parabenzoquinone vapour for 3 hours at 60ºC and infiltrated with Epon-Araldite resin 
(1:1) for 3 hours at 10-2 Torr. Tissue was embedded in resin. The resin was allowed to 
polymerize for 48 hours at 60ºC. Serial 1µm sections were cut and deplasticised in 
sodium ethoxide diluted 1:2 with absolute alcohol for 10minutes. They were washed in 
absolute alcohol, hydrated through 95% alcohol to distilled water prior to execution of 
the Feulgen method.  
 
Sections were rinsed in 1M HCl at room temperature followed by hydrolysis in 1M HCl 
at 60°C. In order to determine optimal hydrolysis time, required for the breaking of 
purine-deoxyribose bonds, sections were incubated in 1M HCl at 60°C for different 
periods ranging from 10 minutes to 1 hour. Sections were thereafter rinsed in 1M HCl at 
room temperature for 1 minute. In order to view the aldehydes resulting from HCl 
hydrolysis, sections were placed in Schiffs reagent (see Appendix I) for 45 minutes and 
rinsed 3 times in bisulphate solution (see Appendix I), followed by washing in distilled 
water. Sections were counterstained by placing them in 1% light green for 2 minutes. 
Sections were washed in distilled water, dehydrated through a graded series of alcohols, 
cleared in xylene and mounted in Entellen. Cell components containing DNA were 
expected to stain purple-red with the surrounding tissue staining a light green colour.  
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3 
RESULTS 
 
3.1 GAIN MODEL OF HEPATIC INJURY 
Liver from untreated animals served as a control with which to compare the histology of 
the GaIN treated livers. The histological structure of the untreated liver revealed classic 
liver lobules with cords of hepatocytes radiating outward from the central vein toward the 
portal tracts (Figure 6). The parenchyma showed no signs of degeneration, presenting 
with both intact hepatic cord structure and sinusoidal spaces (Figure 7). Portal tracts, 
consisting of a bile duct, arteriole and venule were unaffected and demonstrated no 
evidence of oval cell proliferation (Figure 7). 
 
The first animal to receive GaIN at a 70mg/100g body weight dose (Dabeva and Shafritz, 
1993) died prematurely (refer to Table I). The dosage was thus reduced to 40mg 
GaIN/100g body weight with the duration of hepatic injury over 4 days. Histological 
analysis revealed no significant changes to the hepatic parenchyma (Figure 8) when 
compared to that of untreated liver (Figure 6).  Hepatic cord structure remained intact 
with no obvious hepatocyte necrosis or sinusoidal dilation (Figure 9). However, a sparse 
oval cell response in the portal tract area was noted (Figure 9). These cells were identified 
by their palely basophilic oval nuclei, scanty basophilic cytoplasm and oval cell shape.   
 
The dose was thus increased to 50mgGaIN/100g body weight. The duration of hepatic 
injury was also increased to 5 days. The results obtained from this experiment (Figure 10) 
contrast with those obtained from liver treated with 40mg GaIN/100g body weight 
(Figure 8).  Disorganization of hepatic cord structure was apparent at both low and high 
magnifications (Figures 10 and 11, respectively). Although foci of hepatocyte 
degeneration, as evidenced by a scattered increase in eosinophilia, were evident (Figure 
10), few putative oval cells were seen proliferating in the portal tract areas (Figure 11). 
These cells are seen in close association with the bile duct (Figure 11). 
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The dose was thus increased, once again, to 70mgGaIN/100g body weight based on the 
work of Dabeva and Shafritz (1993). The duration of hepatic injury was reduced to 4 
days. The treated liver exhibited disruption of hepatic cord structure (Figure 12), when 
compared with that of the normal liver (Figure 6). An intense inflammatory response, as 
evidenced by the presence of leukocytes exhibiting small, darkly stained nuclei, was 
demonstrated associated with the portal tract (Figure 13). At a higher magnification, 
sinusoidal dilation and atrophy of hepatic plate organization was evident (Figure 14). 
This compares significantly with the structure of untreated liver (Figure 7) and GaIN-
treated livers at 40mg GaIN/100g body weight (Figure 9) and 50mg GaIN/100g body 
weight (Figure 11).  Degenerating hepatocytes (acidophilic bodies) exhibiting an increase 
in cytoplasmic eosinophilia and a loss of nuclear structure were evident (Figure 14). The 
appearance and severity of the aforementioned features was seen to increase 
concomitantly with an increase in GaIN concentration (Figures 9, 11 and 14). 
Furthermore, the proliferation of oval cells, identified by their pale-staining basophilic 
nuclei and scanty cytoplasm, was found in the vicinity of the bile duct (Figure 13). Oval 
cells are seen to invade the hepatic parenchyma in rows (Figure 13), forming atypical 
ducts (Figures 13 and 14).  
 
The duration of hepatic injury was increased to 5 days in rats treated with 70mg 
GaIN/100g body weight, in order to increase the size of the oval cell population 
produced. Liver obtained from these experiments presented with similar pathology as 
seen in those animals treated with the same dose but over a 4 day period, as elucidated in 
the preceding paragraph. However, the severity of those pathologies was enhanced. 
Destruction of hepatocyte plate organization and cord structure, as well as sinusoidal 
dilation, were marked (Figure 15). An increase in scattered eosinophilia (Figure 15), 
indicative of acidophilic bodies was apparent (Figures 16). Putative oval cell 
proliferation, in the immediate surroundings of the portal triad was evident (Figures 16). 
These cells were seen to line existing biliary ducts (Figure 16), and to thus form atypical 
ducts (Figure 17). Oval cells were also seen to form cords extending into the hepatic 
parenchyma (Figure 17).  It was thus established that a 70mg GaIN/100g body weight 
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dose and a duration of hepatic injury extending over a 5 day period, was sufficient to 
induce a significant oval cell population that could be isolated for primary cell cultures. 
 
Table 1 illustrates the number of premature deaths of GaIN-treated rats experienced in 
this study. Prior to death, animals presented with severe weight loss and a tendency to 
bleed in the extremities.  Autolysis of a number of the deceased precluded examination of 
body organs. Independent autopsies conducted on the others indicated severe necrosis of 
the liver parenchyma. Hepatocytes exhibited a loss of nuclear structure, eosinophilia of 
the cytoplasm and ultimate degeneration. Reports by the Central Animal Service 
veterinarian indicated that the evident pannecrosis, a severe lesion, is associated with 
toxin exposure. 
 
Table 1. 
 
 
3.2 THE USE OF CELL-SORTING METHODOLOGY IN THE ESTABLISHMENT OF A PRIMARY 
CELL CULTURE FROM GAIN-TREATED ADULT RAT LIVER 
The establishment of a primary cell culture is dependant on the acquisition of a 
significant number of viable cells from the organ in question. Furthermore, in cell sorting 
procedures based on the labelling of cell markers, these markers should not be adversely 
affected in the preparation of single cell suspensions (Carlsen et al., 1981). As such, the 
technique involved in the production of a single cell suspension is of paramount 
Year Number Killed  Premature Deaths % of Premature 
Deaths 
2004 6 1 16.67% 
2005 9 2 22.22% 
2006 9 5 55.55% 
 Total Number Killed Total Number Premature 
Deaths 
Total % Premature 
Deaths 
 24 8 33.33% 
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importance to the establishment of a primary cell culture. This will be expounded upon 
further in the following chapters. 
 
All the cell sorting procedures used in this study proved ineffective  the resultant 
fraction exhibiting a low yield and an inability to proliferate in culture. The direct method 
of cell sorting incorporated the use of CD90+ microbeads designed for use in a mouse 
model. The lack of specificity could be responsible for the low yield of cells derived from 
treated rat livers. However, the cell fraction obtained from the use of an indirect method 
of cell sorting using CD90 PE-conjugated primary antibody specific for rat tissue 
followed by labelling with Anti-PE microbeads, also produced a low yield of viable cells. 
This precludes reduced specificity as a cause for the ineffectiveness of the cell sorting 
procedure and rather implicates an ineffective isolation of single cell suspensions.  
 
Furthermore, the use of a cell sorting method adapted from Kano et al. (2003) also 
proved ineffective. Although the yield appeared marginally higher, cells were static in 
culture. This yet again implicates the technique used to acquire an initial isolation of 
single cell suspensions, as inefficient. Specifically, the use of both enzymatic and 
mechanical dissociation procedures appear to have irreparably damaged the isolated cells. 
This will be discussed further in ensuing chapters.  
 
Since a primary cell culture could not be established it was thus necessary to use an 
established cell line in order to continue experimentation.  
 
 
3.3 PHESC-A2 CELLS IN CULTURE 
The PHeSC-A2 cell line, donated by Prof. Kano of the University of Tsukuba Japan, is a 
hepatic stem cell-like line derived from a normal porcine model.  These cells have 
properties akin to those of oval cells and are regarded as such in this study. Their 
properties will be expounded upon in the ensuing chapters. Kano et al. (2003), 
established that the successful propagation of the PHeSC-A2 cell line was dependant 
firstly on the substrate on which the cells were to adhere, and secondly, on the medium in 
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which cells were grown. Kano et al. (2003) accordingly investigated a number of systems 
and found that the PDL-NAIR1 culture system was able to maintain both the proliferation 
and the stem-cell properties of the PHeSC-A2 cell line.  
 
The PHeSC-A2 cell line, in this study, was thus cultured on PDL-coated flasks. 
Specifically formulated NAIR-1 medium was changed every two days. In these 
conditions, the cells appear stellate in shape (Figure 18). Clusters of cells were seen to 
proliferate towards each other (Figure 19). As confluency was approached, cells were 
passaged and reseeded in order to produce a sufficient population with which to continue 
experimentation.  
 
 
3.4 IMMUNOLOCALIZATION OF AFP IN PHESC-A2 CELLS 
Immunolocalization of AFP was conducted on 1µm sections of resin-embedded PHeSC-
A2 cells in order to investigate whether they had maintained their oval cell properties in 
culture. The positive control, fourteen and a half day old fetal mouse liver, did not exhibit 
immunolocalization of AFP. The ineffectiveness of the technique was attributed to the 
use of an expired primary antibody (goat polyclonal AFP). As such, results obtained from 
the ICC protocol conducted on PHeSC-A2 cells, were null and void. Since no culture 
parameters were altered in this study from those elucidated in Kano et al. (2003) it was 
thus assumed that the PHeSC-A2 cell properties, as stated in the literature (Kano et al., 
2003), had been maintained in this study.  
 
 
3.5 CO-CULTURE OF PHESC-A2 AND QUAIL PANCREATIC MESODERM 
PHeSC-A2 cells and mesodermal explants were cultured in the GFRM-Hams F12.ITS 
system for 5 days prior to processing for immunolocalization of insulin and glucagon. 
The culture system was arranged such that quail mesoderm lay between two layers of 
PHeSC-A2 cells, surrounded by GFRM (Figure 20). For the duration of the experiment, 
oval cells appeared to aggregate forming a cluster around the mesoderm explant. This 
appeared as an area that assumed a progressively denser appearance over time (Figures 
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20 and 21). The morphology and arrangement of PHeSC-A2 cells cultured in the GFRM-
Hams F12.ITS system differed to those grown in the PDL-NAIR-1 system. In the former 
culture system, most cells remained tightly clustered (Figure 22) while a few others 
assumed a more spindle-shaped morphology (Figure 23). Proliferation was not obviously 
evident (Figure 22). In the latter system (PDL-NAIR-1 system), oval cells did not cluster 
together, but proliferated radially, assuming a stellate structure (Figure 19). This 
morphological variance may be attributable to the different substrates on which they were 
grown. When cultured on PDL-coated flasks in Hams F12.ITS medium (Figure 24), the 
structure of the oval cells is similar to those grown in NAIR-1 medium (Figures 18 and 
19). Since immunocytochemical tests conducted on PHeSC-A2 cells in the PDL-NAIR-1 
system were ineffectual (see 3.4.), no further tests on the cell marker, AFP, were 
conducted on the said cells in either the GFRM-Hams F12.ITS culture system or PDL-
Hams F12.ITS system in this study. As such no inferences as to alterations in the nature 
of their properties, if any did in fact occur, can be made. 
 
Proliferation of quail mesodermal cells varied in different experiments. This difference 
may be due to a reduction in cell viability following removal of the pancreatic mesoderm 
from the quail embryos. Mesoderm was cultured without PHeSC-A2 cells in GFRM as a 
control (Figure 25). The mesodermal cells proliferated extensively, invading the 
surrounding GFRM (Figure 26). Importantly, with respect to both mesodermal and oval 
cell contingencies, cell movement as seen using phase contrast microscopy, may not all 
be attributable to proliferation. Some cell movement may in fact be dissemination of cells 
from the aggregates in which they were seeded. However, no further experimentation was 
done to confirm these movements. 
 
 
3.6 IMMUNOLOCALIZATION OF INSULIN AND GLUCAGON IN QUAIL PANCREATIC MESODERM 
AND PHESC-A2 CO-CULTURES 
3.6.1. Controls 
In order to determine the efficacy of the immunolocalization technique, a positive control 
in which a known sample of tissue (chick pancreatic tissue) possessing both insulin and 
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glucagon-containing cells, was subjected to the ICC process. Insulin and glucagon-
positive cells were localized within the pancreatic islets of the chick pancreas. Glucagon-
positive cells were located in the centre of islets (Figure 27) in the positive control. 
Neither the negative control (Figure 28) nor the absorption control exhibited 
immunolocalization of glucagon (Figure 29), indicating the specificity of the antibody in 
question and the efficacy of the ICC technique. Insulin-positive cells were confined to the 
periphery of the pancreatic islet (Figure 30). No immunolocalization of insulin was found 
in either the negative control (Figure 31) or the absorption control (Figure 32). Neither 
non-specific staining nor background staining was evident in any of the aforementioned 
controls for the immunolocalization of glucagon and insulin (Figures 27  29 and Figures 
30  32, respectively), thus indicating the specificity and the effectiveness of the ICC 
technique.  
 
3.6.2. Experimental tissue: PHeSC-A2 and quail mesoderm co-cultures 
The histological structure of quail cells includes a large, pale-staining, vesicular nucleus 
and a prominent nucleolus (Figure 33). This feature allows for discrimination between 
quail cells and oval cells, the latter having a small, oval-shaped nucleus. As such, 
endodermal contamination of the co-cultures, which would result in the differentiation of 
quail endocrine cells, is immediately recognisable. Quail cells exhibited a light 
background stain with DAB. This is however, easily distinguishable from definitive 
immunolocalization of either glucagon (Figure 27) or insulin (Figure 30) which are 
identified by their dark brown, granular appearance in the positive control tissue.   
 
Insulin-positive cells in the co-cultures were visualised using DAB.  These cells exhibited 
a granular cytoplasm, indicative of insulin-producing cells, and condensed, darkly stained 
nuclei (Figures 34 - 36). These small, oval-shaped nuclei, as well as the appearance of the 
cytoplasm, contrasted significantly with those of quail cells (Figure 33). Insulin-positive 
cells appeared clustered together within the GFRM (Figures 34 - 36). This close 
association is characteristic of the nature in which PHeSC-A2 cells behaved in the 
GFRM-Hams F12.ITS in vitro system (Figures 20 and 21). 
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Glucagon-positive cells, also visualised using DAB, were rare. The nuclei of these cells 
contrasted with those of the quail mesodermal cells (Figure 33), in that they were small, 
oval and did not display a prominent nucleolus (Figure 37). The cytoplasm of glucagon-
positive cells again contrasted with those of quail cells, the former being darkly stained 
and granular in appearance (Figure 37), and the latter exhibiting a low background stain 
(Figure 33). Glucagon-positive cells were also found in clusters, reminiscent of the 
behaviour of oval cells in the in vitro culture system (Figures 20 and 21). Visual 
assessment of insulin and glucagon-positive cell nuclei suggested their origin from 
PHeSC-A2 cells. Although further tests were conducted to affirm this supposition, they 
proved inconclusive, as highlighted in the following paragraphs.  
 
 
3.7 IMMUNOLOCALIZATION OF THE QUAIL NUCLEAR MARKER 
Immunolocalization of the quail nuclear marker was conducted to allow for 
immunocytochemical discrimination between quail cells and PHeSC-A2 cells. However, 
the positive control, quail mesodermal tissue, exhibited no immunolocalization of the 
nuclear marker. The tissue exhibited no background staining or non-specific staining. 
This ICC technique was thus ineffective and could not be used to affirm visual 
identification of insulin and glucagon-positive cells as oval cell-derivations on sections 
adjacent to those exhibiting immunolocalization for the said pancreatic markers. The 
primary antibody used in this study had expired and is thus implicated in the inefficacy of 
the ICC technique. 
 
 
3.8 IDENTIFICATION OF THE QUAIL NUCLEAR MARKER USING THE FEULGEN METHOD 
The Feulgen method, which demonstrates DNA, has previously been used in chick-quail 
recombination studies to identify the quail nucleus. In this study it was intended to 
discriminate between quail and porcine cells and thereby confirm that insulin and 
glucagon were expressed by differentiated PHeSC-A2 cells, thus excluding the possibility 
of a quail pancreatic endodermal contaminant.  
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This technique, however, also proved ineffective. This is attributed to the manner in 
which the tissue was fixed in this study (freeze-drying, followed by fixation in 
parabenzoquinone vapour). The fixative used is critical to the efficacy of the Feulgen 
technique since it impacts directly on the hydrolysis of DNA by HCl (Bancroft and Cook, 
1996). Although different hydrolysis times were investigated, none proved efficient and 
no DNA staining was evident. 
 
The results obtained do indicate the presence of putative insulin-positive and glucagon-
positive cells within the PHeSC-A2 and pancreatic mesoderm co-cultures, as determined 
by immunocytochemical techniques. By virtue of their cell and nuclear size, they have 
been identified as oval cell-derived cells. Quail cells as highlighted in preceding 
paragraphs, exhibit a large, round, vesicular nucleus with a prominent nucleolus. This 
contrasts with the nuclei of both the insulin-positive and glucagon-positive cells  being 
small, oval and lacking a prominent nucleolus. As such it is proposed that these cells 
were derived from PHeSC-A2 cells. Techniques designed to confirm the nature of insulin 
and glucagon-producing cells, were ineffective and could thus not be used to affirm the 
visual observations. Further studies are required to confirm the ability of pancreatic 
mesenchyme to induce the differentiation of oval cells to pancreatic endocrine cells. The 
results obtained in this study provide a basis with which to continue further 
experimentation both into mesodermal capabilities and the plasticity of oval cells. 
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4 
DISCUSSION AND CONCLUSIONS 
 
4.1 THE ROLE OF GAIN IN HEPATIC INJURY 
The role of GaIN as a model for hepatic injury is based on its hepatotoxic effect. The 
action of this agent is associated with a rapid depletion of uracil nucleotides and 
consequently the inhibition of protein, glycoprotein, glycolipid, glycolipoprotein and 
phosphoprotein synthesis in hepatocytes (Dabeva and Shafritz, 1993; Kmieć et al., 2000). 
The ensuing structural and functional damage to the liver, characteristically similar to 
acute hepatitis, is necessary for the activation of the oval cell compartment (Ferenčíková 
et al., 2003). Oval cells are not targeted by the action of GaIN and thus act to restore the 
hepatic parenchyma by proliferation and differentiation along the hepatic lineage. This is 
a compensatory mechanism which is activated when the regenerative capacity of 
hepatocytes is impaired, as in the GaIN model of hepatic injury (Dabeva and Shafritz, 
1993). 
 
As evidenced in this study, degenerating hepatocytes exhibited an increase in cytoplasmic 
eosinophilia and loss of nuclear structure. Furthermore, hepatic cord structure was 
markedly disrupted with hepatocytes assuming an acinar arrangement.  It was established 
in this study that the degeneration of the hepatic parenchyma increased in severity 
concomitantly with an increase in the dosage of GaIN. Furthermore, an increase in 
putative oval cell proliferation was also seen to be dependant on higher concentrations of 
GaIN, as well as on the duration of hepatic injury. Morphologically, oval cells are 10µm 
in size, with a large nuclear-cytoplasmic ratio and oval nucleus (Zhang et al., 2003). This 
morphology was used to identify oval cells in this study. Moreover, oval cell nuclei were 
found to stain palely basophilic and were surrounded by scant basophilic cytoplasm, as 
reported by Dabeva et al. (1993). Oval cells were seen to proliferate in the periportal 
areas, in close association with the bile ducts. These cells were seen to invade the hepatic 
parenchyma as cords. The presence of both small hepatocytes and atypical duct structures 
are reminiscent of the ability of oval cells to differentiate into both hepatocytes and bile 
ductular cells (Dabeva et al., 1993).   
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Dabeva and Shafritz (1993) have determined that oval cells are capable of restoring the 
hepatic parenchyma, re-establishing normal liver function and thus allowing GaIN-
treated animals to resume their health. In this study, however, a number of animals died 
unexpectedly resulting in the termination of Animal Ethics Approval by the Animal 
Ethics Committee (AEC) of the University of the Witwatersrand for this part of 
experimentation.   
 
The percentage of animals which died prematurely is illustrated in Table I. Of the 33.33% 
of untimely deaths, one animal succumbed at a 50mg GaIN/100g body weight dose and 
others at a 70mg GaIN/100g body weight dose. In Table I it can be noted that the number 
of premature deaths doubled year to year, from 2004. Animals exhibited severe weight 
loss, with a tendency to bleed at the extremities.  Autopsy reports revealed severe 
necrosis of the liver parenchyma with degeneration of the hepatocytes. This included loss 
of nuclear structure and an increase in the eosinophilia of hepatocyte cytoplasm. Such 
pannecrosis is a severe lesion associated with toxin exposure. It was thus put forth by the 
AEC firstly, that the GaIN dose used was too high and secondly, that the toxicity of GaIN 
was directly responsible for the premature deaths of these animals.  
 
Despite the association of hepatic necrosis with the effects of GaIN, the restoration of the 
liver parenchyma by putative progenitor cell proliferation has been documented. This 
forms the basis of the current understanding of oval cell behaviour and the subsequent 
reconstitution of the liver mass when hepatocyte replication is impeded. Although 
published work does not state the number of premature deaths that may have occurred in 
the duration of their research, personal correspondence with Dr. Dabeva (of Dabeva and 
Shafritz, 1993) from the Albert Einstein College of Medicine, New York, on whose work 
the dose was based, includes the following revelations.  
 
Firstly, the 70mg GaIN/100g body weight dose is well tolerated by wild-type animals 
such as Sprague-Dawley rats. GaIN itself was purchased a number of times in the 
duration of this study, thereby precluding the possibility of batch contamination. 
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Moreover, GaIN is purchased from the same company used by Dabeva (personal 
communication). Furthermore, due to decreased levels of purity of GaIN, Dabeva 
(personal communication) has increased the dose to 110mg GaIN/100g body weight  
almost twice the dose used in this study. It is therefore unlikely that the 70mg GaIN/100g 
body weight dose was too concentrated for toleration by the animals in this study. 
 
Dabeva (personal communication) also highlighted the possibility of the exposure of 
these animals to an endotoxin, contact with which increases several-fold the effects of 
GaIN, notwithstanding that endotoxins are themselves capable of inducing hepatic injury. 
According to Galanos et al. (1979) variation occurs between and within animal species 
with regard to their reaction to the lethality of endotoxins. They postulated that GaIN 
increased the sensitivity of animals to this toxic effect. In their study, rabbits, Lewis rats 
and mice were used and kept under pathogen-free conditions. Lipopolysaccharide was 
purified from Salmonella arbortus equi and Lipid A was purified from Salmonella 
minnessota R345. The mice and rats received the endotoxins via IP injection, either 
combined with GaIN or immediately after GaIN administration (Galanos et al., 1979). 
The GaIN dosage was 30mg/100g body weight  an amount sufficient to induce 
sensitization to endotoxin (1µg -10µg) in rats. An injection consisting of GaIN + 10µg 
endotoxin resulted in 100% death while GaIN + 1µg endotoxin resulted in a 50% death 
rate, 6-9 hours after administration (Galanos et al., 1979). Also, in rabbit and mouse 
control groups (rat data not reported), receiving GaIN sans endotoxin, no deaths were 
recorded (Galanos et al., 1979).   
 
It was thus found by Galanos et al. (1979) that the administration of GaIN increased the 
susceptibility of animals to an endotoxin several thousandfold. Sensitivity was at its 
highest when the endotoxin was introduced together with GaIN or soon after GaIN 
administration. This sensitization has been linked to the early metabolic effect that GaIN 
has on the liver. It has thus been postulated that transient changes in metabolic activity 
can result in increased susceptibility of an animal to small amounts of endotoxin (Galanos 
et al., 1979).   
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According to Dr. Herbst (personal communication) of the Albert Einstein College of 
Medicines Animal Institute, New York reagent sterility and aseptic technique are of 
particular importance, in light of the influence of endotoxins. In this study GaIN 
concentrates were prepared with sterile saline and filtered prior to use. Trained personnel 
administered the majority of injections. The animals, however, were not disinfected prior 
to injection. It is thus possible that at this stage, bacteria from the surface were introduced 
into the peritoneal cavity. Following this communication, the site of injection was 
alcohol-sterilised. This did not however, prevent the ensuing premature deaths. 
 
The effects of bacterial translocation during GaIN treatment need also be taken into 
account. Normally, the involvement of immunoglobulins, local and systemic 
macrophages and mucosal barriers prevent the translocation of enteric bacteria (Kasravi 
et al., 1996). Such translocation may intensify the extent of damage caused by acute 
hepatic injury. In order to investigate such a phenomenon, Kasravi et al. (1996), 
administered 110mg GaIN/100g body weight to Sprague Dawley rats via an 
intraperitoneal injection. It was found that the intestinal mucosa was adversely affected, 
with permeability increasing concomitantly with decreasing arterial blood pressure. 
Furthermore, liver macrophages, activated by GaIN, release inflammatory mediators that 
not only enhance the hepatotoxic effect of GaIN, but also adversely affect the intestinal 
mucosa (Shiratori et al., 1988).  Furthermore, macrophages have also been implicated in 
the active translocation of enteric bacteria (Kasravi et al., 1996). Despite a number of 
studies, bacterial translocation is a poorly understood phenomenon, with varying 
aetiologies and complications and thus remains a controversial subject. Nevertheless, 
such evidence may be used to explain the high rate of premature deaths experienced in 
this study. Further exploration in this area need be done before re-attempting to use the 
GaIN model of hepatic injury in the study of oval cell activation. 
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4.2. ESTABLISHMENT OF PRIMARY CELL CULTURES FROM GAIN-TREATED ADULT RAT 
LIVER 
The establishment of a primary cell culture proved problematic. Perfusion using a 0.05% 
collagenase solution followed by mechanical dissociation of the tissue did not yield a 
significant viable cell contingent. Carlsen et al. (1981) have investigated the properties of 
single cell suspensions of hepatocytes obtained both from enzymatic dissociation and 
mechanical dissociation of tissue. Both methods of isolation have adverse effects on cell-
surface properties and consequently affect the propagation of cells in culture. Although a 
number of studies have used these methods in the isolation of single cell suspensions, 
minor alterations in methodology may have profound effects on cell properties and 
consequently, behaviour (Carlsen et al., 1981). The cell suspensions obtained in this 
study did not propagate in culture. This could be attributed to a low cell yield or to 
excessive disruption of intercellular communication systems. 
 
The use of magnetic microbeads for direct and indirect labeling of oval cells and 
subsequent sorting in a high gradient magnetic field proved unsuccessful. The efficacy of 
the use of magnetic microbeads in the sorting of cell populations in other studies has been 
documented (Servida et al., 1996). However, this is dependant on the use of a single cell 
suspension with a significant yield of viable cells, as well as on the specificity of the 
microbeads used. Histological observations of the GaIN-treated liver in this study (70mg 
GaIN/100g body weight) revealed proliferation of a significant oval cell population 
however the single cell suspension obtained from these livers did not provide a 
significant yield of viable cells. Furthermore, the CD90+ microbeads used in the direct 
labeling technique were not specific to rat and were intended for cell sorting in mouse 
samples. Indirect labeling however, incorporated the use of a CD90 PE-conjugated 
primary antibody specific for rat tissue, followed by labeling with Anti-PE microbeads. 
However, the resultant fraction did not proliferate in culture. A low cell yield was also 
obtained from the cell sorting method adapted from Kano et al. (2003) and was incapable 
of proliferating in culture. The establishment of a primary cell culture failed despite the 
use of three various techniques, a failure which is attributable to an ineffective isolation 
of a single cell suspension. This not only highlights the importance of appropriate and 
  33 
 
effective tissue dissociation protocols but also that minor alterations in methodology may 
have profound effects on the resultant single cell suspension. Since a primary cell culture 
with which to continue experimentation was not obtained, the donation of a cell line 
(PHeSC-A2) by Prof. Kano of the University of Tsukuba, Japan, allowed for the 
progression of this study.  
 
4.3. DERIVATION OF THE PHESC-A2 CELL LINE BY KANO ET AL. (2003) 
Kano et al. (2000) investigated the differentiating capacity of the non-parenchymal 
epithelial cell fraction derived from porcine liver. Earlier work conducted by Kano et al. 
(2000) established that normal adult porcine liver contained a population of progenitor 
cells. The methodology used in the preparation of a non-parenchymal cell suspension 
thus precluded the use of hepatic injury models. The derivation of putative progenitor 
cells from untreated animals are of especial interest in lieu of the premature deaths of 
GaIN-treated rats experienced in this study.  
 
Cells isolated by Kano et al. (2000) were plated on  type-I collagen-coated culture dishes 
and propagated in specifically formulated NAIR-1 medium. Forty-eight hours after 
plating, clusters of cells began to proliferate and scatter, forming colonies (Kano et al., 
2000). Cells observed in the central region of these colonies were of a smaller size. It was 
found that 96% of scattered cell clusters developed duct-like structures, indicating a 
correlation between scattering and the emergence of such structures (Kano et al., 2000). 
In vivo, proliferating oval cells, themselves non-parenchymal in nature, are known to 
invade the surrounding parenchyma, either differentiating into hepatocytes or organizing 
themselves into ductular structures (Alison and Sarraf, 1998). This remarkable 
phenomenon, was evidenced in this study, in haematoxylin and eosin-stained sections of 
GaIN-treated liver, and is reminiscent of the development of ductular structures identified 
in the in vitro studies conducted by Kano et al., (2000).  
  
Furthermore, the in vitro studies elucidated in the preceding paragraph by Kano et al. 
(2000) demonstrated that during the scattering stage, the cell clusters tested positive for 
the immature liver marker, AFP and hepatocyte marker, albumin, affirming their oval cell 
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nature as defined by other studies (Lemire et al., 1991; Wang et al., 2003). At the stage of 
duct-like structural development, these markers were expressed in subsets of cells 
surrounding the structures themselves and more strongly, at the periphery of the colonies 
(Kano et al., 2000). Markers associated with biliary epithelial cells, CK19, CK14 and 
GGT, were expressed by cells forming duct-like structures but were not detected in the 
rest of the cells constituting the colonies. These markers are also associated with oval 
cells (Gordon et al., 2000; Hixson et al., 1997).  
 
Kano et al. (2000) also investigated the expression of oval cell antigens OV.6 and OC.2. 
It was found that the scattered clusters of cells were OV6-postive but OC.2 negative. 
Cells constituting the duct-like structures expressed both these antigenic markers. 
Furthermore, these cells stained positive for vimentin, an intermediate mesenchymal 
filament (Kano et al., 2000). Vimentin is also expressed by migrating oval cells. The co-
expression of the mentioned cytokeratins and intermediate filaments, amongst others, are 
postulated to play a role in the migratory behaviour of cancerous cells (Alison and Sarraf, 
1998). Oval cells have been implicated in the development of certain types of liver 
cancers, notably cholangiocarcinomas  adenocarcinomas of bile duct epithelium 
(Underwood, 2000; Grompe, 2003).  
 
The biliary nature of oval cells is further highlighted in their proposed origins  the bile 
ductules, specifically, the canals of Hering, (Alison and Sarraf, 1998). It is postulated that 
oval cells are the progeny of intrahepatic stem cells residing either within the lining of the 
canals of Hering, or surrounding these ducts (Alison and Sarraf, 1998; Fausto, 2000). In 
this study, oval cell proliferation was seen to be closely associated with the bile ductules. 
Petersen et al. (1997), have demonstrated that damage to the biliary system, using 
methylene dianiline, prevents the proliferation of oval cells (Petersen et al., 1997). 
Conversely, further studies conducted by Petersen et al. (1997) found that oval cell 
proliferation was not disrupted when using an acute dose of methylene dianiline followed 
by bile duct ligation (Petersen et al., 1999). This implicated the derivation of oval cells 
from circulating haematopoietic stem cells. The demonstration by Kano et al. (2000), of 
the existence of hepatic progenitor cells in normal adult porcine liver could preclude the 
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invasion of haematopoietic stem cells as a compensatory mechanism for hepatocyte 
dysfunction and instead highlight the origin of oval cells as intra-hepatic. It is, however, 
plausible that haematopoietic stem cell involvement in liver regeneration is a 
compensatory mechanism for oval cell dysfunction, akin to the role oval cells themselves 
play when hepatocyte function is impeded. Haematopoietic stem cells are capable of 
differentiating into a myriad of cell types including skeletal and cardiac muscle, neurons, 
pneumocytes and hepatocytes (Alison, 2002). Petersen (2001) proposes that the oval cell 
compartment is a transitional compartment wherein haematopoietic stem cells 
differentiate into the hepatic lineages. That oval cells express a number of haematopoietic 
markers (Alison and Sarraf, 1998) is also of interest. Whether this feature could be linked 
to the embryological role of the liver in haemopoiesis is however, unknown.  Despite 
such speculation it remains obvious that oval cells have yet to be fully characterized, their 
participation in hepatic regeneration yet to be fully comprehended and their capacity to 
differentiate yet to be fully investigated. Kano et al. (2003) have proposed that their 
establishment of a hepatic stem cell line is essential to the analysis of these cells and may 
assist in the understanding of oval cell character and behaviour in an in vitro 
environment. 
 
A non-parenchymal population isolated from normal adult porcine liver was used by 
Kano et al. (2003), to establish a hepatic stem cell-like line (PHeSC-A2), which was 
donated for use in this study. As elucidated in the preceding paragraphs, this fraction was 
shown to contain hepatic progenitor cells with characteristics akin to that of oval cells 
(Kano et al., 2000). It was found that cells cultured on PDL-coated dishes, in specifically 
formulated NAIR-1 medium were able to sustain proliferation through several passages 
(Kano et al., 2000). In this study, it was demonstrated that the PDL-NAIR-1 system is 
essential to the maintenance of PHeSC-A2 cell proliferation, when compared to the 
GFRM-Hams F12.ITS system. In the GFRM-Hams F12.ITS system, PHeSC-A2 cells 
remained tightly aggregated. The cells neither disseminated, as in the case of mesodermal 
cells nor evidenced proliferation over a 5 day culture period. Furthermore, the 
morphology of the PHeSC-A2 cells in this culture system differed to those propagated in 
the PDL-NAIR-1 system.  In the GFRM-Hams F12.ITS culture system, most PHeSC-A2 
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cells remained clustered together with only a few cells assuming the spindle-shaped 
morphology exhibited by PHeSC-A2 cells grown in the PDL-NAIR-1 system.   
 
Kano et al. (2003) found that after seven days in culture, cells from the non-parenchymal 
fraction of porcine liver formed aggregations expressing AFP mRNA, as determined by 
RT-PCR. The aggregations were then isolated and subjected to single cell sorting using 
FACS (Kano et al., 2003). Ultimately two cloned cell lines  designated PHeSC-A1 and 
PHeSC-A2 were established. The characteristics of both cell lines were investigated 
using RT-PCR and immunocytochemical techniques. It was demonstrated that the cell 
lines exhibited immature hepatic phenotypes (Kano et al., 2003). Although spontaneous 
differentiation of some cells into hepatocytes and biliary epithelium were noted, it was 
found that the expression of AFP mRNA increased significantly during each passage 
indicating the maintenance of both the stem-like phenotype and the proliferative capacity 
of the majority of the cells (Kano et al., 2003).  
 
In this study, localization of the AFP marker was attempted. Immunolocalization of AFP 
on positive controls (fourteen and a half day old fetal liver) yielded negative results. It 
thus followed that the efficacy of the primary antibody was significantly reduced and 
would therefore present itself as ineffective in the immunolocalization of AFP on the 
PHeSC-A2 cell line. Considering the battery of tests applied to the PHeSC-A2 cell line 
by Kano et al. (2003), with the results indicative of oval cell phenotypes, the failure of 
the ICC technique in this study was not sufficient to discontinue experimentation. The 
PHeSC-A2 cell line was thus deemed an appropriate cell line with which to continue 
experimentation in this study.  
 
4.4. THE INFLUENCE OF PANCREATIC MESODERM ON PHESC-A2 CELLS 
Pancreatic mesoderm, while essential for the differentiation of endocrine cells from the 
endodermal component of the dorsal and ventral pancreatic buds (Kim et al., 1997), has 
also been shown to repress β-cell differentiation (Duvillié et al., 2006). The inductive 
capability of pancreatic mesoderm is said to be dependant on the developmental stage at 
which it is utilised. Duvillié et al. (2006), have proposed that this phenomenon is 
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essential to the production of a significant pancreatic progenitor population before 
proceeding to the differentiation of specialized cells. The pancreatic mesoderm used in 
this study, obtained from quail embryos at stage 25 have been previously shown to have 
inductive properties, specifically of β-cell differentiation from pancreatic endoderm 
(Kramer et al., 1987). 
 
The influence of pancreatic mesoderm on the differentiation of oval cells (as the PHeSC-
A2 cell line may be referred to in this study, in lieu of their characteristics as highlighted 
in 4.3.), was thus investigated in an in vitro system. A sandwich system was created to 
ensure the close proximity of the PHeSC-A2 cells and the pancreatic mesoderm - 
necessary for the easy diffusion of mesodermal factors to their target. Mesoderm was thus 
placed between two layers of oval cells and covered in its entirety by GFRM prior to the 
addition of Hams F12.ITS medium. Not all 1µm sections obtained from resin-embedded 
co-cultures contained mesodermal tissue, firstly due to the sandwich system used in this 
study and secondly due to the dissemination of mesodermal cells from the explants and 
their ensuing proliferation.   
 
Quail mesoderm was chosen specifically for use in this study, in order to preclude the 
possibility of endodermal contamination and the resultant differentiation of insulin-
positive cells, by morphological discrimination. Quail nuclei are large and exhibit 
prominent nucleoli and are thus distinguishable from PHeSC-A2 cells. The insulin and 
glucagon-positive cells, immunolocalized in this experiment, exhibited small, oval, 
condensed nuclei. This nuclear morphology contrasts dramatically with that of quail cells. 
Insulin and glucagon-positive cells were thus deemed to be PHeSC-A2 cells which had 
been induced to differentiate into pancreatic endocrine cells. Although cells positive for 
the pancreatic markers in question, were few, the proportion of insulin-positive cells 
exceeded that of glucagon-positive cells. This may be attributable to the use of GFRM 
which has previously been shown to increase the proportion of insulin-positive cells 
relative to glucagon-positive cells (Rawdon and Andrew, 1998). This effect has been 
attributed to a reduced concentration of TGF-β1. TGF- β1 has an anti-proliferative action 
on insulin cells (Rawdon and Andrew, 1998) and has also been implicated in the 
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inhibition of hepatocyte proliferation and the induction of hepatocyte apoptosis in normal 
adult liver (Clark et al., 2005). 
 
A number of factors may have contributed to the low yield of the insulin-positive cells 
identified. The PDL-NAIR-1 culture system in which PHeSC-A2 cells are generally 
grown has been specifically formulated to maintain the viability and differentiating 
capacity of the cells in question (Kano et al., 2003). The ability of the GFRM-Hams 
F12.ITS culture system to maintain oval cell viability needs to be determined. Although 
this culture system has been previously shown to promote differentiation of pancreatic 
endocrine cells in cultures of the embryonic chick pancreas (Kramer and Penny, 2003), it 
is nonetheless probable that factors within the said system may have impeded the 
differentiating capacity of the oval cells. It is also possible that the oval cells and 
mesoderm were not in close enough proximity to allow the diffusion of signaling 
molecules to a significant population of oval cells. 
 
In order to confirm visual observations suggesting the derivation of pancreatic endocrine 
cells from hepatic oval cells, immunocytochemical techniques, as well as the Feulgen 
method were conducted to distinguish the quail nuclear marker from PHeSC-A2 cell 
nuclei.  However, positive controls in both techniques exhibited neither 
immmunolocalization of the quail nuclear marker nor the staining associated with the 
Feulgen method. The failure of the immunocytochemcal technique is attributed to the use 
of an expired quail nuclear marker, the primary antibody QCPN mAB. The 
ineffectiveness of the Feulgen technique, designed to demonstrate DNA is most likley 
due to the fixative used in this study (parabenzoquinone vapour). Fixatives used in the 
Feulgen technique are critical to the hydrolysis of DNA by HCl (Bancroft and Cook, 
1996). This hydrolysis is used to break the purine-deoxyribose bond thereby exposing 
aldehydes. The resulting aldehydes are visualized using Schiffs reagent and appear red-
purple (Bancroft and Cook, 1996). This was however, not demonstrated in this study. It is 
therefore put forward that the hydrolysis time was ineffective owing to the fixative, 
parabenzoquinone vapour, used in this study. Since neither the ICC technique nor the 
Feulgen method could identify known quail nuclei, no confirmation barring visual 
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observations of the insulin and glucagon-positive cells indicating their oval cell 
derivation could be made. Further studies are required to affirm these results and thus the 
ability of pancreatic mesenchyme to induce differentiation of oval cells into pancreatic 
endocrine cells.  However, prior to such experimentation, it is firstly necessary to assess 
the proliferative capacity of PHeSC-A2 cells when cultured in GFRM, as well as their 
ability to retain their stem cell-like properties. The former is essential for obtaining a 
significant population of cells within the system in question, whilst the latter is essential 
to their capacity to accept influences from the mesodermal explants.  
 
4.5. MESODERMAL SIGNALS 
As previously mentioned, mesodermal signals are essential for the specification of the 
pancreas and for the differentiation of endocrine cells in the endodermal component of 
the dorsal and ventral pancreatic buds (Kim et al., 1997; Kumar et al., 2003). Rossi et al. 
(2001) have proposed that BMP signaling from the septum transversum mesenchyme, 
plays a role in hepatogenesis by priming foregut endoderm to respond to FGF signaling 
from cardiac mesenchyme, without which putative hepatic endoderm reverts to a default 
pancreatic fate. These mesodermal signals can either be permissive or instructive. 
Instructive signals can be defined as those capable of patterning the endoderm, or more 
specifically, establishing a pancreatic domain or pre-pattern within the endoderm. 
Permissive signals, however, are incapable of such patterning and act effectively only on 
endoderm for which a pancreatic fate is already specified (Kumar et al., 2003). These 
signals allow for the maintenance of pancreatic gene expression and further cell 
differentiation.  
 
Kim et al. (1997) have shown that signals from the notochord are also essential to 
pancreatic development, specifically for the formation of the dorsal pancreatic bud. 
Moreover, at stage 11 in chick embryos, the notochord is the only mesodermal 
component in direct contact with prospective pancreatic endoderm. Removal of the 
notochord prevents the expression of pancreatic genes in the dorsal endoderm but not in 
endoderm destined for ventral pancreatic bud fate. However, when combined with non-
pancreatic endoderm, the notochord is incapable of inducing pancreatic gene expression 
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(Kumar et al., 2003). As the only mesodermal contingent in contact with putative 
pancreatic endoderm at that specific developmental stage, this raises a number of 
possibilities. Firstly, that signals from the notochord, may be permissive not instructive; 
secondly, that direct contact with a mesodermal contingent may not be necessary and that 
thirdly, the endoderm in question may be patterned at an earlier stage. Although the 
mechanisms responsible for the patterning of the endoderm have yet to be elucidated, 
mesodermal influences, specifically from pancreatic mesoderm, are essential for the 
differentiation of pancreatic β-cells from pancreatic endoderm (Kim et al., 1997).  
 
According to Kumar et al. (2003), signals from the lateral plate mesoderm as early as 
stage 8 in chick embryos have been shown to be instructive. This occurs prior to 
pancreatic bud formation. These signals induce the expression of a number of pancreatic 
markers including insulin, glucagon and PDX1 (Kumar et al., 2003). Kumar et al. (2003) 
attempted to identify the mesodermal signals responsible for inducing the expression of 
PDX1. Although the nature of these signals remain elusive, Kumar et al. (2003) have 
proposed that the growth factors, activin and a number of the family of BMPs, may play 
a role in the induction of pancreatic fate. PDX1 has also been proposed as the 
transcription factor most likely to differentiate pancreas from liver (Kumar and Melton, 
2003). Although essential for pancreatic development, PDX1 is incapable of 
independently inducing cells toward a pancreatic fate without the assistance of co-factors 
(Kumar and Melton, 2003). Studies conducted by Ahlgren et al. (1996) found that 
pancreatic bud development was initiated in mice with a homozygous mutation for the 
PDX1 gene. The mesenchyme demonstrated normal morphology and function but 
signaling from this contingent was unable to further the development and differentiation 
of the endoderm (Ahlgren et al., 1996).  
 
Such data affirms the role of PDX1 as permissive rather than instructive in the patterning 
of the pancreatic domain. Moreover it highlights the importance of reciprocal 
communication between the mesoderm and endoderm, more specifically known as 
mesenchymal-epithelial interactions.  It must also be noted that pancreatic development 
and differentiation is a multifaceted phenomenon involving an array of signals and 
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transcription factors. Although many may be identified, their roles in isolation may 
appear or may be permissive.  It may therefore only be in complex relationships that a 
variety of factors acting in a cooperative, cohesive manner may assume an instructive 
role.   
 
In the present study is it postulated that oval cells retain a higher level of potentiality than 
previous demonstrated (Kano et al., 2003) and are able to differentiate along either a 
hepatic or pancreatic lineage depending on the surrounding environmental influences. 
This proposition, based on the close embryological association of the pancreas and liver, 
has been validated by a number of studies (Deutsch et al., (2001); Yang et al., (2002). It 
is further postulated in this study, that the role of pancreatic mesoderm in the 
differentiation of endocrine cells from oval cells is permissive. Although it was found 
that oval cells are capable of differentiating into pancreatic endocrine cells under the 
influence of pancreatic mesoderm, further experimentation is needed to validate these 
results and thus the stated hypotheses. 
 
4.6. LIVER-PANCREATIC SWITCHES 
Deutsch et al., (2001), have proposed the existence of a hepatopancreatic stem cell based 
on the developmental relationship between the liver and pancreas, more specifically 
between the liver and the ventral pancreatic bud. The dorsal pancreatic bud arises from 
the dorsal aspect of the foregut endoderm, contrasting with the development of the 
hepatic diverticulum and ventral pancreatic bud from ventral foregut endoderm. Deutsch 
et al. (2001), have thus proposed that the liver and ventral pancreatic bud, arising from 
adjacent areas of the same germ layer, share a common endodermal progenitor cell.  
 
This however, does not preclude the existence of a hepatopancreatic stem cell within the 
dorsal pancreatic endoderm. It has already been established that signals from the lateral 
plate mesoderm play an instructive role in the patterning of the pancreatic domain prior to 
the emergence of either dorsal or ventral buds (Kumar et al., 2003). As such, pancreatic 
stem cells within the endodermal component of both buds should only differ in action 
based on different mesenchymal-epithelial interactions  not on the initial patterning. 
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Moreover, considering that differentiation of endocrine cells occurs in the endodermal 
components of both buds, it follows that although these buds may initially interact with 
signals from different mesodermal sources, the signals themselves would not in fact 
differ. Furthermore, fusion of the dorsal and ventral pancreatic buds, midgestation, (Allan 
and Kramer, 2002) would expose both endodermal components to both mesenchymal 
components, and as such, to similar influences that would require reciprocal interaction 
with appropriate patterning in order to be effective.  
 
A number of studies have investigated the plasticity of pancreatic and hepatic adult 
progenitor cells, more specifically the differentiation of these cells into hepatic and 
pancreatic lineages respectively. Yang et al. (2002) isolated hepatic oval cells from rat 
livers using the 2-AAF hepatic injury model. Flow cytometric cell sorting methodology 
was used to purify the cell sample, retaining cells positive for the CD90 marker. They 
were propagated in serum-free IMDM supplemented with 10ng/ml SCF, 10ng/ml LIF 
and 10ng/ml Flt-3 ligand. During continuous culture, the oval cells expressed markers for 
AFP, CD90, CD34 and c-kit. Cells were induced to differentiate into pancreatic 
endocrine cells by a change of medium to RPMI, supplemented with FBS and containing 
a total of 23.5mM glucose. Cells proliferated as spheroidal aggregates, similar 
morphologically to islet-cell clusters.  
 
Yang et al. (2002) found that differentiation of hepatic progenitor cells into endocrine 
cells was dependant on the withdrawal of LIF from the culture conditions and the 
introduction of a high glucose medium. Differentiating cells expressed markers for 
PDX1, Pax4 and Pax6, as well as markers for the endocrine hormones, insulin and 
glucagon, as determined by RT-PCR. ICC and western blot assays demonstrated the 
presence of insulin and glucagon within differentiated cells. Furthermore, the cell clusters 
were shown to be competent in in vivo studies, actively reversing hyperglycaemia 
following transplantation in diabetic mice. 
 
The differentiation capacity of oval cells has been further highlighted by Nakajima-
Nagata et al. (2004). Hepatic progenitor cells isolated from rat liver were cultured in the 
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presence of 10ng/ml EGF, 20ng/ml HGF, 10mM nicotinamide and 10-7M dexamethasone 
in 0.2% FBS-containing DMEM/F12K medium. It was found that these culture 
conditions were able to induce the differentiation of hepatic progenitor cells into insulin-
producing cells. Furthermore, the forced expression of PDX1 via gene transfection 
protocols in differentiated cells was shown to significantly increase the amount of insulin 
produced, comparable to the amounts produced in an in vivo environment. Using early 
assays Nakajima-Nagata et al. (2004), also identified that the isolated hepatic progenitor 
cells, were positive for the neural stem cell marker, nestin. Zulewski et al. (2001) earlier 
identified multipotential stem cells within the pancreatic islets positive for the nestin 
marker.  Cells were initially cultured in RPMI 1640 medium supplemented with 20ng/ml 
bFGF and 20ngEGF, 10% FBS, 10mmol HEPES buffer, 1mmol/L sodium pyruvate and 
71.5µmol/L β-mercaptoethanol (Zulewski et al., 2001). Although the nestin-positive cells 
exhibited none of the pancreatic markers initially, upon confluence and with the addition 
of HGF, betacellulinn, activin-A and nicotinamide to the media, they were shown to not 
only differentiate into both exocrine and endocrine components of the pancreas, but also 
into cells expressing hepatic phenotypes. Liver-specific markers exhibited included AFP, 
E-cadherin, c-MET and HGF, whilst pancreatic markers included insulin, glucagon and 
IDX1 (Zulewski et al., 2001).  
 
The PHeSC-A2 cell line used in this study had previously been shown to exhibit 
immature hepatic markers (Kano et al., 2003). Whether these cells exhibit pancreatic 
markers is unknown. However, their putative differentiation into insulin and glucagon-
producing cells, as determined using immunocytochemical techniques in this study, 
implicate a higher level of plasticity than demonstrated by Kano et al. (2003). The 
PHeSC-A2 cell line thus needs to be subjected to further experimentation. This 
experimentation could firstly, include further culture of the cell line in the presence of 
pancreatic mesoderm to confirm the results obtained in this study; secondly the plasticity 
of PHeSC-A2 cells could be investigated under the different culture conditions used by 
Yang et al. (2002) and Nakajima-Nagata et al. (2004).  
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The close association of liver and pancreas is further emphasized by studies establishing 
the existence of pancreatic oval cells (Grompe, 2003). Originating within the pancreatic 
ducts, these cells exhibit characteristics of hepatic oval cells. Rao et al. (1989) induced a 
progressive loss of pancreatic exocrine tissue with no involvement of either the 
pancreatic ducts or islets, by the administration of a copper-deficient diet in rats. Cells 
exhibiting the oval cell markers GGT and albumin were identified, increasing in number 
concomitantly with acinar degeneration. Following the withdrawal of the copper-
deficient diet and a recovery period, it was found that islands of hepatocytes occupied the 
majority of the pancreatic tissue (60 80%) (Rao et al., 1989). Furthermore, Dabeva et al. 
(1997) established that pancreatic oval cells are able to differentiate into functional 
hepatocytes following transplantation into hepatic tissue. Moreover, pancreatic oval cell 
derived-hepatocytes are functionally and morphologically indistinguishable from 
hepatocytes derived from transplanted hepatic oval cells.  
 
Although more evidence for the definitive existence of a shared hepatopancreatic stem 
cell needs to be obtained, the findings highlighted in the preceding paragraphs credits a 
higher level of potentiality to both hepatic and pancreatic progenitor cells, whose roles 
traditionally were thought to be restricted to differentiation along their own tissue-
specific lineages. The plasticity of progenitor cells is presently under review by many 
scientific communities (Sell, 2004). Orthodox embryologists maintain that determination 
is unidirectional (Sell, 2004) i.e. that when cells are committed to a certain cell lineage 
they cannot dedifferentiate, a process whereby terminally differentiated cells are induced 
to lose their tissue specific phenotype (Stocum, 2004) or transdifferentiate, a process 
whereby a differentiated cell type is converted to a cell type of another lineage (Horb et 
al., 2003). The transfer of a somatic cell nucleus to an enucleated oocyte followed by 
electrical or chemical stimulation to induce embryogenesis is an example of 
dedifferentiation (Sell, 2004), whilst transdifferentiation has been documented in studies 
of the conversion of liver to pancreas (Horb et al., 2003).  
 
According to Horb et al. (2003), the interconversion of liver and pancreas is facilitated by 
the nature of their organogenesis. Shen et al. (2003) have proposed that tissues that 
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develop adjacent to each other from a common cell sheet will differ from each other by 
the differential expression of either one or a few transcription factors. Horb et al. (2003) 
have suggested that only one developmental decision affecting a small number of genes is 
responsible for the divergence of somatic cells to either a liver or pancreatic fate. As 
such, if terminally differentiated hepatic cells can be directed along a pancreatic lineage, 
more so should it be expected from progenitor cells with a more accessible plasticity. 
Moreover, this brings to the fore the extent of influence exerted by microenvironmental 
factors, both chemical and mechanical, on cell differentiation (Huang and Ingber, 2004), 
regardless of the state of potential embodied by the cell.  
 
4.7 CONCLUSIONS 
Oval cell proliferation was successfully induced in vivo following GaIN administration. It 
was established that a 70mg GaIN/100g body weight dose and a 5 day duration of hepatic 
injury was sufficient to activate the proliferation of a significant oval cell population as 
determined visually. Further investigation of the action of GaIN is, however, required 
prior to continued use of this agent as a model of hepatic injury in lieu of the high 
incidence of premature deaths experienced in this study. Isolation of an oval cell 
population from non-treated liver, as conducted by Kano et al. (2003), should be applied 
across a species range, to ascertain firstly, whether hepatotoxic agents are in fact needed 
for oval cell activation, and secondly whether oval cells remain senescent or assume a 
more active role in the normal turnover of liver cells. Success in this regard would 
preclude the use of hepatotoxic agents and importantly, if applied to a human model, 
could be used for the isolation of oval cells from biopsy samples of liver. Thus, should 
the differentiation of pancreatic β-cells from oval cells and the transplantation thereof, 
prove successful, the initial isolation of oval cells would preclude problems of immune 
rejection. 
 
Although the presence of oval cells in GaIN-treated liver was confirmed in this study, the 
establishment of primary cell cultures from the liver was found to be a precarious science 
whose success was affected by minor changes in technique. This illustrated the value of a 
number of parameters in the isolation of single cell suspensions. Furthermore, the 
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importance of culture systems and the factors within those systems on the maintenance of 
the viability, proliferation and differentiation capacity of cells, in lieu of the propagation 
of the PHeSC-A2 cell line, has also been highlighted. In vitro experimentation is in itself 
limited in application since cultured cells are not representative of the in vivo 
environment from which they are removed or intended to be part of. It is therefore only 
within the in vivo environment that results from in vitro studies can be functionally 
validated. 
 
In order to understand the mechanisms underlying hepatic-pancreatic switches, it is 
necessary to identify the signals responsible firstly, for the patterning of the foregut 
endoderm into pancreas and liver and secondly, for the differentiation of pancreatic 
endocrine cells from pancreatic endoderm. Furthermore, the inherent plasticity of hepatic 
oval cells as well as their relationship to pancreatic oval cells requires thorough 
investigation. The theory of the unidirectionality of determination is in the process of 
being refuted; the implications being that somatic cells are capable of dedifferentiation 
and transdifferentiation and that their limitations may only be the terminology applied to 
them. The extent of influence exerted by microenvironmental factors  intracellular and 
extracellular, mechanical and molecular  are thus under investigation (Huang and 
Ingber, 2004). Signals are now thought not to act in a linear fashion, but rather to induce 
effects as part of a network. The signals themselves are thus seen to possess multiple 
functions dependant on the networks within which they act. Mechanical cues and 
topographical limitations need also be taken into account as able to effect certain 
selective pressures on cell states and fates (Huang and Ingber, 2004).  
 
The tentative results obtained in this study have lead to the following postulations: firstly, 
that the PHeSC-A2 cell line may possess a higher level of potentiality than previously 
demonstrated by Kano et al. (2003), secondly that the potential may be due to the shared 
embryological origins of the pancreas and liver as proposed by Dabeva et al. (1997) and 
thirdly, that permissive signaling from the pancreatic mesoderm may be able to induce 
the differentiation of hepatic oval cells into pancreatic endocrine cells as demonstrated by 
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the results obtained in this study. Further research is however, required to confirm these 
results and to substantiate the aforementioned propositions.  
 
Successful isolation of hepatic stem cells from untreated liver, and the differentiation of 
these cells into pancreatic endocrine tissue, under the influence of pancreatic mesoderm, 
could allow for the in vitro production of a significant β-cell population. The competency 
of this population within the in vivo environment could allow for the repopulation of the 
endocrine component of diabetic pancreata.  The implications of success in this regard 
would be an improved quality of life for diabetics and consequently a significant 
reduction in morbidity and mortality rates.  
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APPENDIX  I 
 
BISULPHITE SOLUTION 
  
10% Potassium metabisulphite 
5ml 1M Hydrochloric acid 
90ml Distilled water 
 
 
 
CALCIUM AND MAGNESIUM FREE TYRODES SOLUTION 
 
Solution A 
500ml Distilled water 
 
2.0g    Sodium chloride 
0.05g Potassium chloride 
0.012g Sodium dihydrogen phosphate 
  
Solution B  
480ml Distilled water 
0.025g Sodium hydrogen carbonate 
  
Solution C  
  
20ml Distilled water 
1g Glucose 
  
Autoclave solutions A and B. Leave solution C overnight in refrigerator. 
On the morning of the experiment add solution B to solution A. Filter solution C into A.  
Add 100µl pen/strep. 
 
           
 
      
CHICK RINGER 
 
8.5g   Sodium chloride 
0.42g Potassium chloride 
0.25g Calcium chloride 
1L Distilled water 
 
Autoclave to sterilise  and add 100µl pen/strep 
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DAB 
  
Solution A  
1mg DAB 
2ml Tris/saline (pH 7.6) 
  
Solution B  
1ml 30% Perhydrol 
29ml Distilled water, chilled 
  
Add 20µl of  Solution B to Solution A. Mix well. 
 
 
 
DILUENT FOR ANTISERA 
  
100ml Tris/saline 
0.25g Sodium azide 
5mg BSA 
40mg EDTA 
1ml Swine serum 
 
         
               
NAIR-1 MEDIUM 
  
1:1 DMEM/Hams F12 
10mmol/L HEPES buffer 
10ng/ml Glucagon 
10µg/ml Insulin 
60ng/ml Hydrocortisone 
25ng/ml EGF 
10µg/ml Transferrin 
50nmol/L Triiodothyronin 
5ng/ml     Sodium selenate 
10mmol/L Nicotinamide 
0.1mmol/L L-ascorbic acid phosphate magnesium salt 
1µg/ml [α]-tocopherole acetate 
50ng/ml Linoleic acid 
5%         Fetal bovine serum 
  
Add 50µl pen/strep per 100ml 
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PBS, PH 7.4 
  
8.5g Sodium chloride  
1.07g Disodium hydrogen orthophosphate 
0.39g Sodium dihydrogen  orthophosphate 
dehydrate  
  
Autoclave to sterilize 
 
 
 
SCHIFFS REAGENT 
  
1g Basic fuschin 
200ml Distilled water, boiling 
Allow to cool to 50°C 
2g Potassium metabisulphite 
Allow to cool to room temperature 
2ml 1N Hydrochloric acid 
2g Activated charcoal 
Leave overnight, at room temperature, in the dark 
Filter and store in dark container at 4°C 
 
      
 
TRIS/SALINE (PH 7.6) 
  
Stock Solution: Tris/HCl (pH 7.6)  
100ml 1M Tris 
76.8ml 1N Hydrochloric acid 
Make up to 2L with distilled water. 
  
Tris/Saline  
500ml Tris/HCl 
42.75g Sodium chloride 
4.5L Distilled water 
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